Processing 00000000.tx.1: Insulin-Degrading Enzyme Does Not Require Peroxisomal Localization for Insulin Degradation1 Valrie Chesneau2,3, Rachel K. 

Phrase: "Insulin-Degrading Enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "Does"

Phrase: "Not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "Require"

Phrase: "Peroxisomal Localization for Insulin Degradation1 Valrie Chesneau2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]
   743   C2262921:peroxisome localisation [Physiologic Function]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "Rachel K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.2: Perlman2, Wenlu Li, Gilbert-Andr Keller and Marsha Rich Rosner Ben May Institute for Cancer Research (V.C., R.K.P., M.R.R.), The University of Chicago, Chicago, Illinois 60637; 

Phrase: "Perlman2,"

Phrase: "Wenlu Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Gilbert-Andr Keller"

Phrase: "and"

Phrase: "Marsha Rich Rosner Ben May"

Phrase: "Institute for Cancer Research"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1516225:Cancer Research [Research Activity]
   819   C0035172:Research Institute [Organization]
   770   C0006826:Cancer [Neoplastic Process]
   770   C0021622:institute [Organization]
   770   C0035168:research [Research Activity]
   770   C0242481:Research [Research Activity]
   770   C0998265:Cancer [Eukaryote]
   770   C1272753:Institute [Idea or Concept]
   770   C1306459:Cancer [Finding]

Phrase: "(V.C.,"

Phrase: "R.K.P.,"

Phrase: "M."

Phrase: "R.R."

Phrase: ")"

Phrase: ","

Phrase: "The University of Chicago,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0008044:Chicago [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "Illinois 60637"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020898:Illinois [Geographic Area]

Phrase: ";"
Processing 00000000.tx.3: Department of Pharmacology (W.L., G.-A.K.), Genetech, Inc., San Francisco, California 94080; 

Phrase: "Department of Pharmacology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "(W.L., G.-A.K."

Phrase: ")"

Phrase: ","

Phrase: "Genetech,"

Phrase: "Inc.,"

Phrase: "San Francisco,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036152:San Francisco [Geographic Area]
   861   C1826357:San [Gene or Genome]

Phrase: "California 94080"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006754:California [Geographic Area]
   861   C3146274:California [Plant]

Phrase: ";"
Processing 00000000.tx.4: Columbia University College of Physicians and Surgeons (R.K.P.), New York, New York 10032 Address all correspondence and requests for reprints to: Marsha Rich Rosner, Ben May Institute for Cancer Research, University of Chicago, 5841 South Maryland Avenue, MC 6027, Chicago, Illinois 60637. 

Phrase: "Columbia University College of Physicians"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0557806:College [Manufactured Object]

Phrase: "and"

Phrase: "Surgeons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582175:surgeons [Professional or Occupational Group]

Phrase: "(R.K.P."

Phrase: ")"

Phrase: ","

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "New York 10032"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0027976:New York [Geographic Area]
   827   C0205314:New [Temporal Concept]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "all correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "requests for reprints"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   756   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "Marsha Rich Rosner,"

Phrase: "Ben May"

Phrase: "Institute for Cancer Research,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1516225:Cancer Research [Research Activity]
   819   C0035172:Research Institute [Organization]
   770   C0006826:Cancer [Neoplastic Process]
   770   C0021622:institute [Organization]
   770   C0035168:research [Research Activity]
   770   C0242481:Research [Research Activity]
   770   C0998265:Cancer [Eukaryote]
   770   C1272753:Institute [Idea or Concept]
   770   C1306459:Cancer [Finding]

Phrase: "University of Chicago,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0008044:Chicago [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "5841 South Maryland Avenue,"

Phrase: "MC 6027,"

Phrase: "Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "Illinois 60637."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020898:Illinois [Geographic Area]
Processing 00000000.tx.5: E-mail: mrosner{at}ben-may.bsd.uchicago.edu  Abstract Top Abstract Introduction Materials and Methods Results Discussion References  Although considerable evidence implicates insulin-degrading enzyme (IDE) in the cellular metabolism of insulin in many cell types, its mechanism and site of action are not clear. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "mrosner{at}ben-"

Phrase: "may.bsd.uchicago.edu  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1514811:Reference [Idea or Concept]
   779   C1706462:Reference [Conceptual Entity]

Phrase: "Although"

Phrase: "considerable evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "implicates insulin-degrading enzyme (IDE)"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in the cellular metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1524026:cellular metabolism [Cell Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in many cell types,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "its mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "site of action"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C2945843:Site of [Qualitative Concept]
   858   C0581718:action site [Intellectual Product]
   790   C0205145:Site [Spatial Concept]
   790   C1515974:Site [Body Location or Region]
   790   C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.6: In this study, we have examined the relationship between insulin-degrading enzymes peroxisomal location and its ability to degrade insulin by mutation of its peroxisomal targeting signal (PTS), the carboxy terminal A/S-K-L tripeptide. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the relationship between insulin-degrading enzymes peroxisomal location"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0439849:Relationship [Qualitative Concept]
   744   C1705630:Relationship [Idea or Concept]
   744   C1706279:Relationship [Idea or Concept]
   744   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "its ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "degrade"

Phrase: "insulin by mutation of its peroxisomal targeting signal (PTS),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]

Phrase: "the carboxy terminal A/S-K-L tripeptide."
Processing 00000000.tx.7: Site-directed mutagenesis was used to destroy the peroxisomal targeting signal of human insulin-degrading enzyme by changing alanine to leucine (AL.pts), leucine to valine (LV.pts), or by deleting the entire tripeptide (DEL.pts). 

Phrase: "Site-directed mutagenesis"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   827   C0079866:Mutagenesis [Molecular Function]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   827   C3146302:Mutagenesis [Laboratory Procedure]
   793   C0439851:Direct [Qualitative Concept]
   793   C1947931:Direct [Qualitative Concept]
   755 E C0439755:Directions [Spatial Concept]
   755 E C0449738:Direction [Spatial Concept]
   711 E C1707761:Directionality [Functional Concept]
   711 E C3274524:Directionality [Functional Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "destroy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681205:Destroy [Idea or Concept]

Phrase: "the peroxisomal targeting signal of human insulin-degrading enzyme"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   742   C1521840:Targeting [Functional Concept]
   742   C1710082:Signal [Phenomenon or Process]
   742   C3546463:peroxisomal [Cell Component]
   708 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "by changing alanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to leucine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(AL.pts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "leucine to valine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(LV.pts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "or by deleting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1880274:Delete [Activity]

Phrase: "the entire tripeptide"

Phrase: "(DEL.pts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.8: The alanine or leucine mutants, when expressed in COS cells, were indistinguishable from wild-type insulin-degrading enzyme with respect to size (110 kDa), amount of immunoreactive material, ability to bind insulin, in vitro activity, and cellular degradation of insulin. 

Phrase: "The alanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "leucine mutants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "when"

Phrase: "expressed in COS cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0376702:COS Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0454802:Cos [Geographic Area]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "indistinguishable from wild-type insulin-degrading enzyme"

Phrase: "with respect to size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:size [Spatial Concept]

Phrase: "(110 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "amount of immunoreactive material,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in vitro activity,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "cellular degradation of insulin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1523935:cellular degradation [Cell Function]
   819   C3547574:insulin degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]
Processing 00000000.tx.9: In contrast, the deletion mutant was shorter in size (0 kDa) and unable to bind the hormone. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the deletion mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "shorter in size"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1282927:short [Qualitative Concept]
   756   C1806781:Short [Quantitative Concept]
   756   C2350002:Short [Quantitative Concept]

Phrase: "(0 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "and"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "the hormone."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019932:Hormone [Hormone]
   928 E C0458083:Hormonal [Qualitative Concept]
Processing 00000000.tx.10: Thus, although the tripeptide at insulin-degrading enzymes carboxy terminus appeared to confer enzyme stability, the conserved sequence was not required for insulin degradation. 

Phrase: "Thus,"

Phrase: "although"

Phrase: "the tripeptide at insulin-degrading enzymes carboxy terminus"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confer"

Phrase: "enzyme stability,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0014439:Enzyme Stability [Molecular Function]
   861   C0205360:Stability [Qualitative Concept]
   861   C2347098:Stability [Qualitative Concept]
   789 E C1547311:Stable [Intellectual Product]

Phrase: "the conserved sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0009802:Conserved Sequence [Nucleotide Sequence]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "required for insulin degradation."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C3547574:insulin degradation [Molecular Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]
   770   C1514873:Required [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.11: Finally, an immunocytofluorescence study showed that, whereas a significant amount of the wild-type protein was localized in peroxisomes, none of the peroxisomal targeting mutants could be detected in these organelles. 

Phrase: "Finally,"

Phrase: "an immunocytofluorescence study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that,"

Phrase: "whereas"

Phrase: "a significant amount of the wild-type protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1550420:Amount type [Classification]
   744   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "localized in peroxisomes,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0392752:Localized [Spatial Concept]
   790   C0752063:Peroxisomes [Cell Component]
   756 E C2984308:Peroxisome [Functional Concept]
   706 E C3546463:peroxisomal [Cell Component]

Phrase: "none of the peroxisomal targeting mutants"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0456148:None [Quantitative Concept]
   753   C0549184:None [Quantitative Concept]
   753   C0596988:mutants [Cell or Molecular Dysfunction]
   753   C1521840:Targeting [Functional Concept]
   753   C3546463:peroxisomal [Cell Component]
   719 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "could"

Phrase: "be"

Phrase: "detected in these organelles."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0029219:Organelles [Cell Component]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.12: These findings indicate that insulin-degrading enzyme does not require peroxisomal localization for insulin degradation and suggest that this enzyme has multiple cellular functions.  

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "indicate"

Phrase: "that insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "peroxisomal localization for insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C2262921:peroxisome localisation [Physiologic Function]
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "has"

Phrase: "multiple cellular functions."
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   884   C0007613:Cellular Function [Cell Function]
   827   C0542341:Functions [Functional Concept]
   793 E C0031843:function [Physiologic Function]
   793 E C0700205:FUNCTION [Classification]
   793 E C1705273:Function [Intellectual Product]
   743 E C0205245:Functional [Functional Concept]
   743 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.13: Introduction Top Abstract Introduction Materials and Methods Results Discussion References  INSULIN IS ONE of a few known factors required by virtually all cell types for optimal growth and proliferation (1), but many of its effects are tissue- or cell-type specific (2). 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "INSULIN"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "IS"

Phrase: "ONE of a few known factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "required by virtually"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514873:Required [Functional Concept]

Phrase: "all cell types for optimal growth"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0449475:Cell types [Intellectual Product]
   783   C0007595:Cell Growth [Cell Function]
   756 E C0007634:Cell Type [Cell]
           Cell
   753   C0332307:Types [Qualitative Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719 E C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "many of its effects"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439064:Many [Quantitative Concept]
   770   C0747726:many [Conceptual Entity]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "tissue-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "or"

Phrase: "cell-type specific"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C0007634:Cell Type [Cell]
           Cell
   901   C0449475:cell type [Intellectual Product]
   827   C0205369:Specific [Qualitative Concept]
   827   C0332307:Type [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1547052:*Type [Quantitative Concept]
   827   C1552740:specific [Intellectual Product]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: Insulin signaling is initiated when the hormone binds to its receptor on the cell surface. 

Phrase: "Insulin signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "is"

Phrase: "initiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548602:Initiate [Idea or Concept]
   966   C1704686:Initiate [Functional Concept]

Phrase: "when"

Phrase: "the hormone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019932:Hormone [Hormone]
   928 E C0458083:Hormonal [Qualitative Concept]

Phrase: "binds to its receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]

Phrase: "on the cell surface."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]
Processing 00000000.tx.15: After binding, the receptor-insulin complex is internalized via receptor-mediated endocytosis, and the internalized insulin is eventually either degraded or released intact (reviewed in 3 . Higher concentrations of insulin are associated with higher percentages of internalized insulin being released intact (4). 

Phrase: "After binding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "the receptor-insulin complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1523873:receptor complex [Cell Component]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]
   734   C0034818:receptor insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]

Phrase: "is"

Phrase: "internalized via receptor-mediated endocytosis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0597361:Receptor Mediated Endocytosis [Cell Function]
   760   C0014139:Endocytosis [Cell Function]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C2984285:Endocytosis [Functional Concept]

Phrase: "and"

Phrase: "the internalized insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "eventually either"

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "or"

Phrase: "released intact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205266:Intact [Qualitative Concept]
   861   C1554187:Intact [Idea or Concept]

Phrase: "("

Phrase: "reviewed in 3 . Higher concentrations of insulin"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   757   C0020459:high insulin [Disease or Syndrome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0086045:Concentrations [Mental Process]
   748   C0282443:reviewed [Intellectual Product]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1709940:Reviewed [Qualitative Concept]
   714   C0205250:High [Qualitative Concept]
   714   C1299351:High [Qualitative Concept]
   714 E C1446561:Concentration [Quantitative Concept]
   714 E C1552617:Review [Idea or Concept]
   714   C2700149:HIGH [Intellectual Product]

Phrase: "are"

Phrase: "associated with higher percentages of internalized insulin"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   757   C0020459:high insulin [Disease or Syndrome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714   C0205250:High [Qualitative Concept]
   714   C0439165:Percentage [Quantitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714   C1299351:High [Qualitative Concept]
   714   C1549488:Percentage [Idea or Concept]
   714   C1561533:Percentage [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
   714   C2700149:HIGH [Intellectual Product]

Phrase: "being"

Phrase: "released intact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205266:Intact [Qualitative Concept]
   861   C1554187:Intact [Idea or Concept]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.16: The degradation of insulin, therefore, may play a role in termination of the signal and/or clearance of the circulating hormone. 

Phrase: "The degradation of insulin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C3547574:insulin degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "therefore,"

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in termination of the signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "and/or"

Phrase: "clearance of the circulating hormone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0449297:Clearance [Qualitative Concept]
   760   C1382187:Clearance [Clinical Attribute]
   760   C2825073:Clearance [Natural Phenomenon or Process]
Processing 00000000.tx.17: The insulin-degrading enzyme (IDE; EC 3.4.22.11) is an evolutionarily conserved neutral thiol metalloprotease able to degrade insulin in vitro with high specificity and very low Km (5). 

Phrase: "The insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "; EC 3.4.22.11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "is"

Phrase: "an evolutionarily conserved neutral thiol metalloprotease able to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0025543:METALLOPROTEASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "degrade"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in vitro with high specificity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "very low Km (5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0442811:Very low [Finding]
   812   C0205251:low [Qualitative Concept]
   812   C0442824:Very [Qualitative Concept]
   812   C1299352:Low [Qualitative Concept]
   812   C1550472:low [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.18: Numerous experiments suggest that IDE is the principal enzyme controlling insulin degradation in many cell types. 

Phrase: "Numerous experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "the principal enzyme controlling insulin degradation in many cell types."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C3547574:insulin degradation [Molecular Function]
   757   C0678637:enzyme degradation [Laboratory Procedure]
   739   C0243125:degradation [Functional Concept]
   739   C0699900:Degradation [Organism Function]
Processing 00000000.tx.19: The sites at which the purified enzyme cleaves insulin in vitro are consistent with the insulin degradation products found in intact liver (6) and cultured cells (7). 

Phrase: "The sites at which"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205145:Sites [Spatial Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "the purified enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "cleaves"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "are"

Phrase: "consistent with the insulin degradation products"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "found in intact liver"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0150312:Found [Quantitative Concept]
   770   C0205266:Intact [Qualitative Concept]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C1554187:Intact [Idea or Concept]
   770   C2346688:LIVER [Food]
   737 E C0243095:Find [Finding]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "(6"

Phrase: ")"

Phrase: "and"

Phrase: "cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.20: Inhibitors of IDE block insulin degradation in a number of cell types (8, 9, 10). 

Phrase: "Inhibitors of"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0243077:inhibitors [Chemical Viewed Functionally]
   799 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "IDE block insulin degradation"
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   877   C3547574:insulin degradation [Molecular Function]
   845   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   845   C0678637:enzyme degradation [Laboratory Procedure]
   845   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   795   C0014442:Enzyme [Enzyme,Organic Chemical]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0028778:Block [Pathologic Function]
   795   C0243125:degradation [Functional Concept]
   795   C0332206:Block [Functional Concept]
   795   C0699900:Degradation [Organism Function]
   795   C1533157:Block [Substance]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   795   C1706084:Block [Geographic Area]
   795   C2828370:Block [Quantitative Concept]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   724 E C2983591:BLOCKED [Research Activity]
   712 E C0014445:enzymes [Functional Concept]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in a number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "(8,"

Phrase: "9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.21: Monoclonal antibodies to IDE can specifically inhibit insulin degradation in HepG2 cells (11), and the protease can be cross-linked to insulin in intact cells (12). 

Phrase: "Monoclonal antibodies to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C0746619:monoclonal [Finding]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "can"

Phrase: "specifically"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulin degradation in HepG2 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C3547574:insulin degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Protease [Enzyme]

Phrase: "can"

Phrase: "be"

Phrase: "cross-linked to insulin"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0178576:Cross Linked [Natural Phenomenon or Process]
   833   C0332220:cross linked [Functional Concept]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C2828360:Cross [Conceptual Entity]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in intact cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0682538:intact cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.22: Moreover, its overexpression in COS cells increases the rate of intracellular insulin degradation severalfold, indicating that IDE catalyzes a rate-determining step in insulin degradation (13). 

Phrase: "Moreover,"

Phrase: "its overexpression in COS cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the rate of intracellular insulin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "severalfold,"

Phrase: "indicating"

Phrase: "that"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "catalyzes"

Phrase: "a rate-determining step in insulin degradation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0871208:Rate [Activity]
   748   C1261552:Step [Conceptual Entity]
   748   C1521828:Rate [Quantitative Concept]
   748   C1704379:Step [Functional Concept]
   748   C1705117:Step [Quantitative Concept]
   748   C2825408:Step [Manufactured Object]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.23: In antigen presenting cells, IDE has also been proposed to mediate the processing of insulin epitopes for helper T cells (14). 

Phrase: "In antigen presenting cells,"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0003315:Antigen-Presenting Cells [Cell]
   827   C0003320:Antigen [Immunologic Factor]
   827   C0007634:Cells [Cell]
   827   C0449450:Presenting [Idea or Concept]
   827   C3282337:Cells [Cell]
   793 E C0150312:Present [Quantitative Concept]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   727 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the processing of insulin epitopes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1158354:insulin processing [Molecular Function]
   760   C1709694:Processing [Activity]

Phrase: "for helper T cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0018894:Helper T-Cells [Cell]
           Helper Cells
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.24: Although the evidence for the role of IDE in degrading insulin is strong, there is increasing evidence that the metalloprotease may have other cellular substrates as well. 

Phrase: "Although"

Phrase: "the evidence for the role of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in degrading insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "strong, there"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442821:Strong [Qualitative Concept]
   789 E C0237897:Strength [Quantitative Concept]
   789 E C0808080:Strength [Idea or Concept]
   789 E C1705922:Strength [Qualitative Concept]

Phrase: "is"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the metalloprotease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025543:METALLOPROTEASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "have"

Phrase: "other cellular substrates as well."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.25: Indeed, in vitro studies have shown that IDE can degrade the related growth factors insulin-like growth factor I and II (15), as well as transforming growth factor (16). 

Phrase: "Indeed,"

Phrase: "in vitro studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0681828:in vitro study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "can"

Phrase: "degrade"

Phrase: "the related growth factors insulin-like growth factor I"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   890   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   890   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   861   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C1753359:insulin-like growth factor [Molecular Function]
   847   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   822   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C0021966:I- [Inorganic Chemical]
   793   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   793   C1579433:Insulin [Pharmacologic Substance]
   737 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   710 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "II"

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "as well as"

Phrase: "transforming growth factor"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.26: Other in vitro substrates that have more recently been identified are atrial natriuretic peptide (17) and oxidatively damaged hemoglobin (18). 

Phrase: "Other in vitro substrates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1710236:Substrate [Manufactured Object]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "that"

Phrase: "have"

Phrase: "more recently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "are"

Phrase: "atrial natriuretic peptide"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0027481:Atrial natriuretic peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0051989:atrial peptide [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1144709:natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C2709270:Natriuretic peptide [Amino Acid, Peptide, or Protein,Hormone]
   901   C3537020:Natriuretic Peptide [Pharmacologic Substance]
   827   C0018792:Atrial [Body Part, Organ, or Organ Component]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0597421:natriuretic [Pharmacologic Substance]
   755 E C0524422:atria [Body Part, Organ, or Organ Component]
   755 E C1280619:Atrium [Body Part, Organ, or Organ Component]

Phrase: "(17"

Phrase: ")"

Phrase: "and"

Phrase: "oxidatively damaged hemoglobin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.27: Although the biological role of IDE remains a fundamental question, its high degree of evolutionary conservation further supports the idea that it must have important functions. 

Phrase: "Although"

Phrase: "the biological role of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "remains"

Phrase: "a fundamental question,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522634:Question [Intellectual Product]

Phrase: "its high degree of evolutionary conservation further"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0441889:Degree [Qualitative Concept]
   748   C0449286:Degree [Quantitative Concept]
   748   C0542560:Degree [Intellectual Product]
   748   C1561545:degree [Quantitative Concept]
   748   C2348088:Degree [Quantitative Concept]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that"

Phrase: "it"

Phrase: "must"

Phrase: "have"

Phrase: "important functions."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.28: Rat, Drosophila, and bacterial homologs have been cloned that have 95%, 47%, and 26% identity, respectively, with the complementary DNA (cDNA)-deduced amino acid sequence of the human enzyme (19, 20, 21, 22). 

Phrase: "Rat,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "Drosophila,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013138:Drosophila [Eukaryote]
  1000   C1028876:Drosophila [Fungus]
  1000   C1504613:Drosophila [Eukaryote]

Phrase: "and"

Phrase: "bacterial homologs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1334043:Homolog [Gene or Genome]
   755 E C2697616:Homology [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "that"

Phrase: "have"

Phrase: "95%,"

Phrase: "47%,"

Phrase: "and"

Phrase: "26% identity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0424215:Identity [Mental Process]
   861   C2003939:Identity [Finding]

Phrase: "respectively,"

Phrase: "with the complementary DNA (cDNA)-deduced amino acid sequence"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   876   C0162326:DNA Sequence [Nucleotide Sequence]
           Sequence
   861   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   827   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C2917660:Amino Acid [Pharmacologic Substance]
   799   C0001128:Acid [Chemical]
   799   C0004793:Sequence [Nucleotide Sequence]
   799   C0162327:Sequence [Nucleotide Sequence]
   799   C0202406:Acid [Laboratory Procedure]
   799   C1519249:Sequence [Functional Concept]
   727 E C1548958:Sequential [Idea or Concept]
   727 E C1705294:Sequential [Qualitative Concept]

Phrase: "of the human enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "(19,"

Phrase: "20,"

Phrase: "21,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.29: More recently, two members of the IDE family have been identified in yeast Saccharomyces cerevisiae (23), and three in Caenorhabditis elegans. 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "two members of the"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0680022:members [Population Group]
   737 E C2698041:Member [Professional or Occupational Group]

Phrase: "IDE family"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0015576:Family [Family Group]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1704727:Family [Conceptual Entity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   733 E C0241888:Familial [Functional Concept]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "identified in yeast Saccharomyces cerevisiae"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0036025:Saccharomyces cerevisae [Fungus]
           yeast
   797   C2598686:Yeast identified [Laboratory or Test Result]
   760   C0036024:Saccharomyces [Fungus]
   760   C0043392:Yeast [Food]
   760   C0043393:Yeast [Fungus]
   760   C0205396:Identified [Qualitative Concept]
   760   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "three in Caenorhabditis elegans."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0162610:Caenorhabditis elegans [Eukaryote]
   770   C0006638:Caenorhabditis [Eukaryote]
   770   C0205449:Three [Quantitative Concept]
Processing 00000000.tx.30: In addition to an overall homology, IDE contains several conserved functional motifs. 

Phrase: "In addition to an overall homology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1334043:Homology [Gene or Genome]
   861   C2697616:Homology [Qualitative Concept]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "several conserved functional motifs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1514562:Motif [Amino Acid Sequence]
Processing 00000000.tx.31: We recently verified that the conserved HXXEH sequence in the human IDE is a zinc binding motif that serves as the core of IDEs active site (5, 24). 

Phrase: "We recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "verified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verified [Functional Concept]

Phrase: "that"

Phrase: "the conserved HXXEH sequence in the human"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0009802:Conserved Sequence [Nucleotide Sequence]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1519249:Sequence [Functional Concept]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "a zinc binding motif"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1148621:zinc binding [Molecular Function]
   827   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1514562:Motif [Amino Acid Sequence]
   827   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "that"

Phrase: "serves as the core of IDEs active site"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C0205681:Active Site [Functional Concept]
   767   C2945843:Site of [Qualitative Concept]
   744   C0205145:Site [Spatial Concept]
   744   C0205177:Active [Functional Concept]
   744   C0328104:Ide [Fish]
   744   C0444669:Core [Spatial Concept]
   744   C1167518:core [Cell Component]
   744   C1415875:IDE [Gene or Genome]
   744   C1515974:Site [Body Location or Region]
   744   C1706352:Core [Medical Device]
   744   C1882467:Core [Manufactured Object]
   744   C2825164:Site [Spatial Concept]
   744   C2826366:IDE [Idea or Concept]
   744   C3274653:Core [Body Substance]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.32: Comparison of the amino acid sequences of the human, rat and Drosophila IDEs has also revealed a conserved carboxy-terminal peroxisomal targeting signal, A/S-K-L (25, 26). 

Phrase: "Comparison of the amino acid sequences of the human,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1707455:Comparison [Activity]

Phrase: "rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "and"

Phrase: "Drosophila IDEs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0328104:Ide [Fish]
   861   C1415875:IDE [Gene or Genome]
   861   C2826366:IDE [Idea or Concept]

Phrase: "has"

Phrase: "also"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a conserved carboxy-terminal peroxisomal targeting signal,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   799   C1521840:Targeting [Functional Concept]
   799   C1710082:Signal [Phenomenon or Process]
   799   C3546463:peroxisomal [Cell Component]
   766 E C2986546:TARGET [Diagnostic Procedure]
   727 E C0752063:Peroxisomes [Cell Component]
   727 E C2984308:Peroxisome [Functional Concept]

Phrase: "A/S-K-L (25,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.33: Peroxisomes are single-membrane-bound organelles involved in the generation and degradation of H2O2, in plasmalogen synthesis, cholesterol and bile acid synthesis, purine and amino acid catabolism, glyoxylate utilization, and prostaglandin metabolism (27, 28). 

Phrase: "Peroxisomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]

Phrase: "are"

Phrase: "single-membrane-bound organelles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   888   C1523865:membrane-bounded organelle [Cell Component]
   812   C0029219:Organelles [Cell Component]

Phrase: "involved in the generation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0079411:Generation [Temporal Concept]
   770   C1314939:Involved [Functional Concept]
   770   C3146294:Generation [Activity]

Phrase: "and"

Phrase: "degradation of H2O2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "in plasmalogen synthesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "and"

Phrase: "bile acid synthesis,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1157403:bile acid synthesis [Molecular Function]
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]
   734   C0005390:Bile acid [Biologically Active Substance,Steroid]
   734   C2917673:Bile Acid [Pharmacologic Substance]
   706 E C0376167:Choleic Acid [Biologically Active Substance,Pharmacologic Substance,Steroid]

Phrase: "purine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034140:Purine [Organic Chemical]
  1000   C0220903:purine [Organic Chemical]

Phrase: "and"

Phrase: "amino acid catabolism,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0543484:catabolism [Functional Concept]
   827   C0699900:Catabolism [Organism Function]
   827   C1516314:Catabolism [Physiologic Function]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "glyoxylate utilization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042153:utilization [Functional Concept]

Phrase: "and"

Phrase: "prostaglandin metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1158364:prostaglandin metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "(27,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.34: Peroxisomal proteins are synthesized on free polysomes and are directed into the organelle posttranslationally by at least two pathways dependent on distinct peroxisomal targeting signals (PTS1 and PTS2). 

Phrase: "Peroxisomal proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "synthesized on free polysomes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0032592:Polysomes [Cell Component]
   770   C0332296:free [Functional Concept]
   770   C1880497:Free [Qualitative Concept]
   770   C1883254:Synthesized [Activity]
   770   C1996904:Free [Qualitative Concept]
   770   C2324468:Polysomes [Cell Component]

Phrase: "and"

Phrase: "are"

Phrase: "directed into the organelle posttranslationally"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0029219:Organelle [Cell Component]
   726   C0439851:Direct [Qualitative Concept]
   726   C1947931:Direct [Qualitative Concept]

Phrase: "by"

Phrase: "at least two pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "dependent on distinct peroxisomal targeting signals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "(PTS1"

Phrase: "and"

Phrase: "PTS2"

Phrase: ")."
Processing 00000000.tx.35: The PTS1 signal is a C-terminal tripeptide (SKL or a variant), whereas PTS2 is a NH2-terminal peptide (29). 

Phrase: "The PTS1 signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "is"

Phrase: "a C-terminal tripeptide"

Phrase: "(SKL"

Phrase: "or"

Phrase: "a variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:Variant [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "PTS2"

Phrase: "is"

Phrase: "a NH2-terminal peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.36: IDE from human, rat, and Drosophila contains a conserved PTS1 (A/S-K-L), but the homologous protease from Escherichia coli does not. 

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "from human,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "rat,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "and"

Phrase: "Drosophila"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013138:Drosophila [Eukaryote]
  1000   C1028876:Drosophila [Fungus]
  1000   C1504613:Drosophila [Eukaryote]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a conserved PTS1"

Phrase: "(A/S-K-L),"

Phrase: "but"

Phrase: "the homologous protease from Escherichia coli"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C1947941:Protease [Enzyme]

Phrase: "does"

Phrase: "not."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]
Processing 00000000.tx.37: A number of studies have now shown that IDE is indeed located in peroxisomes in mammalian cells. 

Phrase: "A number of studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "indeed"

Phrase: "located in peroxisomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0752063:Peroxisomes [Cell Component]
   756 E C2984308:Peroxisome [Functional Concept]
   706 E C3546463:peroxisomal [Cell Component]

Phrase: "in mammalian cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.38: In subcellular fractionation studies using rat liver, IDE cosedimented with peroxisomal markers (30). 

Phrase: "In subcellular fractionation studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C1656251:subcellular fractionation [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "rat liver,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "cosedimented with peroxisomal markers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C3546463:peroxisomal [Cell Component]
   737   C0005516:Marker [Clinical Attribute]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.39: Recently, we have established stable Ltk- cell lines in which induction of IDE expression results in increased cellular insulin degradation (31). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "we"

Phrase: "have"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "stable Ltk- cell lines in which induction of"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   776   C0598091:stable cell line [Cell]
   770   C0007600:Cell lines [Cell]
   744   C0007634:Cell [Cell]
   744   C0205132:lines [Spatial Concept]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   711 E C1550648:Line [Substance]
   711 E C1552960:Line [Quantitative Concept]

Phrase: "IDE expression"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "results in increased cellular insulin degradation"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   790   C3547574:insulin degradation [Molecular Function]
   783   C0020459:increased insulin [Disease or Syndrome]
   783   C1523935:cellular degradation [Cell Function]
   753   C0007634:Cellular [Cell]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0178539:Cellular [Functional Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0243125:degradation [Functional Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0699900:Degradation [Organism Function]
   753   C1274040:Result [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1546471:Result [Idea or Concept]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C2825142:Result [Finding]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.40: Immunofluorescence and immunocryoelectron microscopy revealed that IDE in these cells was localized primarily in peroxisomes, although a lesser amount was found in the cytosol. 

Phrase: "Immunofluorescence"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0016318:Immunofluorescence [Laboratory Procedure]
  1000   C0079603:Immunofluorescence [Laboratory Procedure]
   944 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   928 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "immunocryoelectron microscopy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "primarily in peroxisomes,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0752063:Peroxisomes [Cell Component]
   756 E C2984308:Peroxisome [Functional Concept]
   706 E C3546463:peroxisomal [Cell Component]

Phrase: "although"

Phrase: "a lesser amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "found in the cytosol."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0150312:Found [Quantitative Concept]
   770   C1383501:Cytosol [Cell Component]
   737 E C0243095:Find [Finding]
Processing 00000000.tx.41: Similar observations have been recently made in transfected CHO cells (32). 

Phrase: "Similar observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "have"

Phrase: "been"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "made in transfected CHO cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0085080:CHO Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726   C1881534:Make [Functional Concept]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.42: In the present study, we have made changes in the peroxisomal targeting signal of IDE that block IDE transport to peroxisomes. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "changes in the peroxisomal targeting signal of"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "that block"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]
   928 E C2983591:BLOCKED [Research Activity]

Phrase: "IDE transport"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   840   C1750080:enzyme transport [Cell Function]
   804   C0005528:Transport, NOS [Cell Function]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1317949:Transport [Manufactured Object]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C3495449:transport [Medical Device]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "to peroxisomes."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]
Processing 00000000.tx.43: Analysis of these mutants showed that IDE does not require peroxisomal localization for insulin degradation. 

Phrase: "Analysis of these mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "peroxisomal localization for insulin degradation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C2262921:peroxisome localisation [Physiologic Function]
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]
Processing 00000000.tx.44: The enzyme may thus participate in several distinct physiological processes.  

Phrase: "The enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "may"

Phrase: "thus"

Phrase: "participate in several distinct physiological processes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0031845:Physiological Processes [Physiologic Function]
   753   C0205463:Physiological [Functional Concept]
   719   C1184743:Process [Body Part, Organ, or Organ Component]
   719   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.45: Materials and Methods Top Abstract Introduction Materials and Methods Results Discussion References  Materials Restriction enzymes were purchased from either Life Technologies, Inc. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials Restriction enzymes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   867   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]
   827   C0443288:Restriction [Functional Concept]

Phrase: "were"

Phrase: "purchased from either Life Technologies,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0039421:technologies [Occupation or Discipline]
   760   C0376558:Life [Idea or Concept]
   760   C0869011:purchased [Activity]

Phrase: "Inc."
Processing 00000000.tx.46: (Grand Island, NY) or New England Biolabs (Beverly, MA). 

Phrase: "(Grand Island,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022130:Island [Geographic Area]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "New England Biolabs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027965:New England [Geographic Area]

Phrase: "(Beverly,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.47: Insulin and BSA were purchased from Sigma (St. Louis, MO). 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "BSA"

Phrase: "were"

Phrase: "purchased from Sigma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]

Phrase: "(St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.48: Disuccinimidyl suberate was from Pierce. 

Phrase: "Disuccinimidyl suberate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0058479:disuccinimidyl suberate [Organic Chemical,Pharmacologic Substance]
   861   C0947344:Suberate [Organic Chemical]

Phrase: "was from Pierce."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.49: Prestained standard SDS-PAGE molecular weight markers were purchased from Bio-Rad (Richmond, CA). 

Phrase: "Prestained"

Phrase: "standard SDS-PAGE molecular weight markers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   839   C0005516:molecular markers [Clinical Attribute]
           Marker

Phrase: "were"

Phrase: "purchased from Bio-Rad (Richmond,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0869011:purchased [Activity]

Phrase: "CA)."
Processing 00000000.tx.50: Nytran membranes were purchased from Schleicher and Schuell (Keene, NH). 

Phrase: "Nytran membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "purchased from Schleicher"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "and"

Phrase: "Schuell"

Phrase: "(Keene,"

Phrase: "NH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0268059:NH [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.51: 125I-Insulin (A14 monoiodinated receptor grade, 2200 Ci/mmol) was purchased from DuPont-New England Nuclear (Boston, MA). 

Phrase: "125I-Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(A14 monoiodinated receptor grade,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0441800:Grade [Classification]
   812   C0919553:Grade [Classification]
   812   C3244287:grade [Finding]

Phrase: "2200 Ci/mmol)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439190:MMOLE [Quantitative Concept]

Phrase: "was"

Phrase: "purchased from DuPont-New England"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0027965:New England [Geographic Area]
   760   C0014282:England [Geographic Area]
   760   C0205314:New [Temporal Concept]
   760   C0331805:DuPont [Health Care Related Organization]
   760   C0869011:purchased [Activity]

Phrase: "Nuclear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "(Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.52: 125I-Protein A was a gift from Geoffrey Green of the Ben May Institute or purchased from DuPont-NEN. 

Phrase: "125I-Protein A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "a gift from Geoffrey Green of the Ben May Institute"

Phrase: "or"

Phrase: "purchased from DuPont-NEN."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0331805:DuPont [Health Care Related Organization]
   770   C0869011:purchased [Activity]
Processing 00000000.tx.53: Oligonucleotides were obtained from Operon (Alameda, CA) or from Paul Gardner of the Howard Hughes Institute of the University of Chicago. 

Phrase: "Oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "obtained from Operon"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0029073:Operon [Gene or Genome]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(Alameda,"

Phrase: "CA)"

Phrase: "or from Paul Gardner of the Howard Hughes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1551730:Hughes [Population Group]

Phrase: "Institute of the University of Chicago."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0008044:Chicago [Geographic Area]
   753   C0021622:institute [Organization]
   753   C0041740:University [Manufactured Object,Organization]
   753   C1272753:Institute [Idea or Concept]
Processing 00000000.tx.54: Polyclonal antibodies to IDE (antiserum 2BS) were produced by immunizing rabbits with trpE fusion proteins containing amino acids 118 to 508 of human IDE (33). 

Phrase: "Polyclonal antibodies to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   849   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(antiserum 2BS"

Phrase: ")"

Phrase: "were"

Phrase: "produced by immunizing rabbits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0034493:Rabbit [Mammal]

Phrase: "with trpE fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   867   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "amino acids 118 to 508 of human"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   778   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0001128:Acids [Chemical]
   748   C0086418:Human [Human]
   745 E C2917660:Amino Acid [Pharmacologic Substance]
   714 E C0202406:Acid [Laboratory Procedure]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.55: Monoclonal antibodies to human IDE (antibody 31H7) were a gift from Richard Roth of Stanford University (11). 

Phrase: "Monoclonal antibodies to human"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0746619:monoclonal [Finding]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(antibody 31H7"

Phrase: ")"

Phrase: "were"

Phrase: "a gift from Richard Roth of Stanford University"

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.56: Monoclonal antibodies to the hemagglutinin1 (HA) epitope were purchased from Berkely Antibody Company (Richmond, CA). 

Phrase: "Monoclonal antibodies to the hemagglutinin1 (HA) epitope"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0746619:monoclonal [Finding]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "purchased from Berkely Antibody Company"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0683757:Company [Manufactured Object,Organization]
   760   C0869011:purchased [Activity]

Phrase: "(Richmond,"

Phrase: "CA)."
Processing 00000000.tx.57: General techniques COS and Ltk- cells were grown in DMEM supplemented with 10% FBS (Life Technologies, Inc.). 

Phrase: "General techniques COS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0454802:Cos [Geographic Area]

Phrase: "and"

Phrase: "Ltk- cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in DMEM"

Phrase: "supplemented with 10% FBS (Life Technologies,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0039421:technologies [Occupation or Discipline]
   753   C0376558:Life [Idea or Concept]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.58: Protein concentrations were estimated by a modified Bradford (34) assay (Bio-Rad). 

Phrase: "Protein concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427716:Protein concentration [Laboratory Procedure]
   983   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "estimated by a modified Bradford"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0205349:Modified By [Qualitative Concept]
   760   C0392747:Modified [Functional Concept]
   760   C0750572:Estimated [Quantitative Concept]

Phrase: "(34"

Phrase: ")"

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "(Bio-Rad"

Phrase: ")."
Processing 00000000.tx.59: SDS-PAGE was done using the conditions of Laemmli (35). 

Phrase: "SDS-PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "was"

Phrase: "done"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the conditions of Laemmli"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.60: Production of mutated plasmids pCMVhIDE was constructed by inserting the 3.4 kb cDNA for human insulin-degrading enzyme into pCMVo as previously described (13). 

Phrase: "Production of mutated plasmids pCMVhIDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "constructed by inserting"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0441587:Insert [Health Care Activity]
   756   C1743766:Insert [Medical Device]
   756   C1883719:Insert [Functional Concept]
   756   C2827421:Construct [Classification]

Phrase: "the 3.4 kb cDNA for human insulin-degrading enzyme"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "into pCMVo"

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.61: The PTS mutants were created using the unique site elimination mutagenesis kit from Pharmacia as described (36). 

Phrase: "The PTS mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "created"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706214:Created [Activity]
   966 E C3244320:create [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the unique site elimination mutagenesis kit from Pharmacia"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0812225:KIT [Medical Device]
   744   C1150635:KIT [Molecular Function]
   744   C1705212:Kit [Medical Device]
   744   C1705213:KIT [Medical Device]
   744   C3273202:Kit [Manufactured Object]

Phrase: "as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.62: Briefly, the kit uses a two-primer system to generate site-specific mutations (37). 

Phrase: "Briefly,"

Phrase: "the kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0812225:KIT [Medical Device]
  1000   C1150635:KIT [Molecular Function]
  1000   C1705212:Kit [Medical Device]
  1000   C1705213:KIT [Medical Device]
  1000   C3273202:Kit [Manufactured Object]

Phrase: "uses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "a two-primer system to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "generate"

Phrase: "site-specific mutations"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0449604:site specific [Spatial Concept]
   827   C0026882:Mutations [Genetic Function]
   827   C0205145:Site [Spatial Concept]
   827   C0205369:Specific [Qualitative Concept]
   827   C1515974:Site [Body Location or Region]
   827   C1552740:specific [Intellectual Product]
   827   C2825164:Site [Spatial Concept]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.63: The first primer carried the desired mutation, either 3106GC to CT for AL.pts, 3112C to G for LV.pts, and a deletion of nucleotides 3106 to 3114 for DEL.pts. 

Phrase: "The first primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "the desired mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "either 3106GC to CT"

Phrase: "for AL.pts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]

Phrase: "3112C to G"

Phrase: "for LV.pts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]

Phrase: "and"

Phrase: "a deletion of nucleotides 3106"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1442161:Deletion [Cell or Molecular Dysfunction]
   760   C1511760:Deletion [Genetic Function]
   760   C1880274:Deletion [Activity]

Phrase: "to 3114"

Phrase: "for DEL.pts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]
Processing 00000000.tx.64: (The nucleotide positions refer to the sequence published in 20 .) The second primer carried a mutation in an XbaI site, which was a unique site in the pCMVo vector and was in a nonessential region of the vector. 

Phrase: "("

Phrase: "The nucleotide positions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "refer to the sequence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C0205543:refer [Functional Concept]
   770   C1519249:Sequence [Functional Concept]

Phrase: "published in 20 ."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034037:Published [Occupational Activity]
   790   C1704324:Published [Intellectual Product]

Phrase: ")"

Phrase: "The second primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "a mutation in an XbaI site,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "which"

Phrase: "was"

Phrase: "a unique site in the pCMVo vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "was in a nonessential region of the vector."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0017446:Region [Geographic Area]
   744   C0043194:WAS [Disease or Syndrome]
   744   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0205147:Region [Spatial Concept]
   744   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0442335:Vector [Spatial Concept]
   744   C1421478:WAS [Gene or Genome]
   744   C1705099:Vector [Idea or Concept]
Processing 00000000.tx.65: Both mutations were incorporated simultaneously by primer-directed DNA polymerization using pCMVhIDE as a template. 

Phrase: "Both mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "incorporated"

Phrase: "simultaneously by primer-directed DNA polymerization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0206416:DNA primer [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0314672:Polymerisation [Phenomenon or Process]
   753   C0521115:simultaneously [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "pCMVhIDE as a template."
Processing 00000000.tx.66: After amplification in bacteria, plasmids were screened by digestion with XbaI. 

Phrase: "After amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517480:Amplification [Molecular Biology Research Technique]
  1000   C1521871:Amplification [Phenomenon or Process]
  1000   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "in bacteria,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0004611:Bacteria [Bacterium]
  1000   C1510439:bacteria [Functional Concept]
  1000   C2347473:% Bacteria [Quantitative Concept]
   928 E C0521009:Bacterial [Qualitative Concept]

Phrase: "plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "screened by digestion"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0012238:Digestion [Organism Function]
   790   C2349986:Digestion [Research Activity]
   756   C0220908:screen [Health Care Activity]
   756   C1305399:screen [Functional Concept]
   756   C1705053:Screen [Medical Device]
   734 E C0443277:Peptic [Functional Concept]

Phrase: "with XbaI."
Processing 00000000.tx.67: Clones that had lost this unique site were then sequenced to choose cDNAs with the appropriate mutations. 

Phrase: "Clones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]

Phrase: "that"

Phrase: "had"

Phrase: "lost"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0745777:Lost [Functional Concept]

Phrase: "this unique site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "choose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Choose [Activity]

Phrase: "cDNAs with the appropriate mutations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.68: The plasmids containing the hemagglutinin (HA) epitope-tagged wtIDE and AL.pts were constructed as previously described (36). 

Phrase: "The plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the hemagglutinin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018909:Haemagglutinin, NOS [Immunologic Factor]

Phrase: "(HA"

Phrase: ")"

Phrase: "epitope-tagged wtIDE"

Phrase: "and"

Phrase: "AL.pts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]

Phrase: "were"

Phrase: "constructed as previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C2827421:Construct [Classification]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.69: Transfection of DNA DNA for transfection was purified by CsCl gradient centrifugation followed by RNase digestion and centrifugation through 1 M NaCl to remove oligoribonucleotides (38). 

Phrase: "Transfection of DNA DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "for transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "was"

Phrase: "purified by CsCl gradient centrifugation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0007703:Centrifugation [Laboratory Procedure]
   760   C0055134:CsCl [Inorganic Chemical,Pharmacologic Substance]
   760   C0439182:% gradient [Quantitative Concept]
   760   C0812409:Gradient [Quantitative Concept]
   760   C1998793:Purified [Functional Concept]

Phrase: "followed by RNase digestion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0012238:Digestion [Organism Function]
   770   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C2349986:Digestion [Research Activity]
   737 E C1719822:Follow [Intellectual Product]
   715 E C0443277:Peptic [Functional Concept]

Phrase: "and"

Phrase: "centrifugation through 1 M NaCl to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "oligoribonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028956:Oligoribonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.70: Mutant plasmids were transfected with pSV2CAT into COS cells by calcium phosphate precipitation as previously described (13). 

Phrase: "Mutant plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "transfected with pSV2CAT"

Phrase: "into COS cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0376702:COS Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "by calcium phosphate precipitation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0032931:Precipitation [Natural Phenomenon or Process]
   827   C0032932:Precipitation [Molecular Function]
   827   C1642401:% precipitation [Quantitative Concept]
   827   C2584299:Precipitation [Natural Phenomenon or Process]
   734   C0006711:calcium phosphate [Inorganic Chemical,Pharmacologic Substance]
   734   C0006712:Calcium/Phosphate [Inorganic Chemical,Pharmacologic Substance]
   734   C1161320:calcium phosphate [Pharmacologic Substance]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.71: Cells were harvested or assayed 3648 h after glycerol shock. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "or"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "3648 h after glycerol shock."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.72: For the immunocytofluorescence study, COS and Ltk- cells were replated 6 h after glycerol shock and grown on glass coverslips for another 20 h. 

Phrase: "For the immunocytofluorescence study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "COS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454802:Cos [Geographic Area]

Phrase: "and"

Phrase: "Ltk- cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "replated"

Phrase: "6 h after glycerol shock"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0444953:H 6 [Intellectual Product]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "grown on glass coverslips"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017596:Glass [Manufactured Object]
   770   C1947936:Glass [Medical Device]

Phrase: "for another 20 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.73: Preparation of cell extracts and Western blot analysis Preparation of cell extracts and Western blotting were performed as previously described (24). 

Phrase: "Preparation of cell extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0920433:cell preparation [Laboratory Procedure]
   770   C0455052:Preparation [Health Care Activity]
   770   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "Western blot analysis Preparation of cell extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0920433:cell preparation [Laboratory Procedure]
   748   C0455052:Preparation [Health Care Activity]
   748   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "were"

Phrase: "performed as previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.74: For Western blot analysis, 50 g of each cell extract were electrophoresed under reducing conditions, and proteins were blotted onto nitrocellulose with a HoefferSem-Phor transfer apparatus. 

Phrase: "For Western blot analysis,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "50 g of each cell extract"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0524983:G cell [Cell]
   753   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "electrophoresed under reducing conditions,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0392756:Reducing [Qualitative Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0013855:electrophorese [Laboratory Procedure]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "and"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "blotted onto nitrocellulose"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   706 E C0009357:Collodion Cotton [Biomedical or Dental Material,Pharmacologic Substance]

Phrase: "with a HoefferSem-Phor transfer apparatus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0243111:apparatus [Manufactured Object]
   812   C1947951:Apparatus [Anatomical Structure]
Processing 00000000.tx.75: Blots were probed with 1/200 dilutions of antiserum 2BS (33) or preimmune serum. 

Phrase: "Blots"

Phrase: "were"

Phrase: "probed with 1/200 dilutions of antiserum 2BS"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   744   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0079240:dilutions [Laboratory Procedure]
   711   C0182400:Probe [Medical Device]
   711   C1704681:Probe [Gene or Genome]
   711 E C1948037:Dilution [Functional Concept]
   711   C2347609:Probe [Chemical Viewed Functionally]
   711   C3536729:Probe [Manufactured Object]

Phrase: "(33"

Phrase: ")"

Phrase: "or"

Phrase: "preimmune serum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]
Processing 00000000.tx.76: Insulin degradation assays Cellular degradation of insulin was assayed as previously described (24). 

Phrase: "Insulin degradation assays Cellular degradation of insulin"

Phrase: "was"

Phrase: "assayed as previously"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.77: Briefly, COS cells on 100-mm plates were washed once with isotonic PBS, preincubated 30 min in 4 ml binding buffer (1 mg/ml BSA in DMEM) and then switched to 4 ml of 100 pM 125I-insulin in binding buffer. 

Phrase: "Briefly,"

Phrase: "COS cells on 100-mm plates"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0376702:COS Cells [Cell]
   783   C1441340:100 cells [Cell]
   767   C1166718:cells plate [Cell Component]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once with isotonic PBS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1720092:Once [Intellectual Product]
   770   C1720830:PBS [Disease or Syndrome]
   770   C1823521:PBS [Gene or Genome]
   770   C1948045:Once [Temporal Concept]

Phrase: "preincubated"

Phrase: "30 min in 4 ml binding buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0456693:/30 min [Temporal Concept]
   778   C1442458:30 min [Temporal Concept]
   774   C0439445:mL/min [Quantitative Concept]
   748   C0702093:/min [Temporal Concept]

Phrase: "(1 mg/ml BSA in DMEM"

Phrase: ")"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "switched to 4 ml of 100 pM 125I-insulin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0662713:PM 100 [Organic Chemical]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0439526:/mL [Quantitative Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   708   C1707719:Switch [Manufactured Object]

Phrase: "in binding buffer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.78: Triplicate 150 l aliquots were taken at each time points, and undegraded insulin was precipitated by addition of one volume of 30% trichloroacetic acid. 

Phrase: "Triplicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triplicate [Quantitative Concept]

Phrase: "150 l aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "taken at each time points,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   773   C2348792:Time Point [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C1883727:Taken [Conceptual Entity]
   760   C3541383:Time [Temporal Concept]
   726 E C1515187:Take [Health Care Activity]
   726   C1552961:Point [Quantitative Concept]
   726   C2347617:point [Quantitative Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "undegraded insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "precipitated by addition of one volume of 30% trichloroacetic acid."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   739   C0001128:Acid [Chemical]
   739   C0202406:Acid [Laboratory Procedure]
   739   C0205447:One [Quantitative Concept]
   739   C0449468:*Volume [Quantitative Concept]
   739   C1690016:% volume [Qualitative Concept]
   739   C1705102:Volume [Intellectual Product]
   739   C1883712:Addition [Functional Concept]
   739   C2700258:Volume [Laboratory Procedure]
   706   C1882443:PRECIPITATE [Phenomenon or Process]
Processing 00000000.tx.79: Acid-soluble label at time zero was taken as a blank. 

Phrase: "Acid-soluble label at time zero"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0181496:Label [Manufactured Object]
   753   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "was"

Phrase: "taken as a blank."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0750479:blank [Finding]
   770   C1883727:Taken [Conceptual Entity]
   737 E C1515187:Take [Health Care Activity]
Processing 00000000.tx.80: To assay conditioned medium, the binding buffer was collected after 30 min (before addition of label) and was centrifuged to remove any detached cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "conditioned medium,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "the binding buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "collected after 30 min ("
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]

Phrase: "before addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of label"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0181496:Label [Manufactured Object]
  1000   C2827499:Label [Governmental or Regulatory Activity]

Phrase: ")"

Phrase: "and"

Phrase: "was"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "any detached cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.81: Then, 100 pM 125I-insulin was added to the conditioned medium and 150 l aliquots were taken after the indicated time of incubation at 37 C. 

Phrase: "Then,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "100 pM 125I-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "added to the conditioned medium"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0009647:Conditioned [Mental Process]
   760   C0439536:Medium [Quantitative Concept]
   760   C1524062:Added [Functional Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]
   726 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "150 l aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "taken after the indicated time of incubation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0040223:Time [Temporal Concept]
   748   C1444656:Indicated [Finding]
   748   C1883727:Taken [Conceptual Entity]
   748   C3541383:Time [Temporal Concept]
   714 E C1515187:Take [Health Care Activity]

Phrase: "at 37 C."
Processing 00000000.tx.82: Undegraded insulin was precipitated by the addition of one volume of 30% trichloroacetic acid. 

Phrase: "Undegraded insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "precipitated by the addition of one volume of 30% trichloroacetic acid."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   756   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   738   C0001128:Acid [Chemical]
   738   C0202406:Acid [Laboratory Procedure]
   738   C0205447:One [Quantitative Concept]
   738   C0449468:*Volume [Quantitative Concept]
   738   C1690016:% volume [Qualitative Concept]
   738   C1705102:Volume [Intellectual Product]
   738   C1883712:Addition [Functional Concept]
   738   C2700258:Volume [Laboratory Procedure]
   704   C1882443:PRECIPITATE [Phenomenon or Process]
Processing 00000000.tx.83: In vitro assay of IDE activity was performed as previously described (13), using aliquots of cellular extract containing 1 g protein. 

Phrase: "In vitro assay of"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   909   C1515653:In Vitro Assay [Research Activity]
   833   C0021135:In Vitro [Intellectual Product]
   833   C1533691:in vitro [Qualitative Concept]
           vitro
   833   C2827718:In Vitro [Functional Concept]
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C1510438:Assay [Laboratory Procedure]

Phrase: "IDE activity"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   875   C1145751:insulin activity [Molecular Function]
   840   C0243102:enzyme activity [Molecular Function]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1561536:*Activity [Idea or Concept]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "performed as previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "aliquots of cellular extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1510844:Aliquot [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1 g protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.84: Affinity labeling Insulin affinity labeling was performed as previously described (36). 

Phrase: "Affinity labeling Insulin affinity labeling"

Phrase: "was"

Phrase: "performed as previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.85: Briefly, aliquots of COS cell extracts containing equal amounts of total protein were added to 0.5 nM 125I-insulin, 50 mM HEPES (pH7.5), 50 mM NaCl, and 1 mg/ml BSA in a total volume of 100 l. 

Phrase: "Briefly,"

Phrase: "aliquots of COS cell extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1510844:Aliquot [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "equal amounts of total protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "added to 0.5 nM 125I-insulin,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0444499:0/5 [Quantitative Concept]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0312860:NM [Cell Function]
   748   C1524062:Added [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714 E C1883712:Add [Functional Concept]

Phrase: "50 mM HEPES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(pH7.5"

Phrase: ")"

Phrase: ","

Phrase: "50 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "1 mg/ml BSA in a total volume of 100 l."
Processing 00000000.tx.86: Nonspecific labeling was assessed by addition of 3.3 M unlabeled insulin. 

Phrase: "Nonspecific labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "was"

Phrase: "assessed by addition of 3.3 M unlabeled insulin."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441923:M+ [Intellectual Product]
   742   C1516048:Assessed [Activity]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1883712:Addition [Functional Concept]
Processing 00000000.tx.87: 5 l of 3 mg/ml disuccinimidyl suberate in dimethyl sulfoxide was added to each tube. 

Phrase: "5 l of 3 mg/ml disuccinimidyl suberate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C2348935:.5 L [Quantitative Concept]
   767   C0439268:mg/L [Quantitative Concept]
   767   C1635169:mL/L [Quantitative Concept]

Phrase: "in dimethyl sulfoxide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012403:Dimethyl Sulfoxide [Organic Chemical,Pharmacologic Substance]
   861   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0038771:sulfoxide [Organic Chemical]
   861   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "added to each tube."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0175730:Tube [Medical Device]
   770   C1524062:Added [Functional Concept]
   770   C1547937:Tube NOS [Intellectual Product]
   770   C1561954:tube [Conceptual Entity]
   770   C1704730:TUBE [Medical Device]
   737 E C1883712:Add [Functional Concept]
Processing 00000000.tx.88: After 60 min incubation on ice, the cross-linking reactions were terminated by addition of SDS-gel electrophoresis sample buffer. 

Phrase: "After 60 min incubation"

Phrase: "on ice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]

Phrase: "the"

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "terminated by addition of SDS-gel electrophoresis sample buffer."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   764   C0596607:Gel Electrophoresis [Laboratory Procedure]
   762 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   742   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0013855:Electrophoresis [Laboratory Procedure]
   742   C0017243:Gel [Biomedical or Dental Material]
   742   C0370003:Sample [Substance]
   742   C1382104:Gel [Substance]
   742   C1553404:terminated [Idea or Concept]
   742   C1883712:Addition [Functional Concept]
   742   C2347026:Sample [Conceptual Entity]
   742   C2348570:Terminated [Functional Concept]
Processing 00000000.tx.89: The samples were then heated and electrophoresed, and cross-linked proteins were visualized by autoradiography of the dried gel. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "heated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "electrophoresed,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013855:electrophorese [Laboratory Procedure]

Phrase: "and"

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "visualized by autoradiography of the dried gel."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0004400:Autoradiography [Laboratory Procedure]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0234621:Visualized [Functional Concept]
   748   C1382104:Gel [Substance]
   748   C1512080:Dried [Qualitative Concept]
   748   C2827485:Dried [Body Substance]
Processing 00000000.tx.90: Immunocytofluorescence microscopy Fixation and immunofluorescence labeling of transfected COS and Ltk- cells were performed by a modification of the method previously described (39). 

Phrase: "Immunocytofluorescence microscopy Fixation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0185023:Fixation [Therapeutic or Preventive Procedure]
   827   C0728733:fixation [Mental Process]
   827   C1522662:Fixation [Laboratory Procedure]

Phrase: "and"

Phrase: "immunofluorescence labeling of transfected COS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1167624:Labeling [Mental Process]
   760   C1947902:Labeling [Manufactured Object]
   760   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "Ltk- cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "performed by a modification of the method previously"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C1550369:Performed By [Qualitative Concept]
   744   C0025663:Method [Intellectual Product]
   744   C0392747:Modification [Functional Concept]
   744   C0449851:Method [Functional Concept]
   744   C0871511:METHOD [Intellectual Product]
   744   C0884358:Performed [Functional Concept]
   744   C1554963:modification [Qualitative Concept]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.91: Briefly, cells plated on coverslips were fixed for 30 min in 10% buffered formalin, permeabilized for 5 min with 0.2% Triton in 3% buffered formalin, and blocked for 30 min with 5% dry milk in PBS pH 7.2. 

Phrase: "Briefly,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "plated on coverslips"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0005971:Plate [Medical Device]
   756   C1139930:plate [Medical Device]
   756   C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "fixed for 30 min"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C0702093:/min [Temporal Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "in 10% buffered formalin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1550067:10% Formalin [Biomedical or Dental Material,Organic Chemical]
   913   C1561470:10% Formalin [Intellectual Product]
   827   C0949307:Formalin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "permeabilized for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "with 0.2% Triton"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242759:Triton [Geographic Area]

Phrase: "in 3% buffered formalin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0949307:Formalin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "blocked for 30 min"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C0702093:/min [Temporal Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "with 5% dry milk"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0026131:Milk [Body Substance]
   827   C0349374:Milk [Food]
   827   C0444318:Milk [Substance]
   827   C2825079:Milk [Food]
   771 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   771 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   755 E C0443260:Milky [Finding]

Phrase: "in PBS pH 7.2."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C1882074:pH 7 [Qualitative Concept]
   812   C0020283:[pH] [Quantitative Concept]
   812   C0450407:ph+ [Finding]
   812   C0450408:ph++ [Finding]
   812   C0450409:ph+++ [Finding]
   812   C1720830:PBS [Disease or Syndrome]
   812   C1823521:PBS [Gene or Genome]
Processing 00000000.tx.92: 31H7 antibody to IDE (11) was used at the 75 g/ml final concentration. 

Phrase: "31H7 antibody to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(11"

Phrase: ")"

Phrase: "was"

Phrase: "used at the 75 g/ml final concentration."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   770   C1300565:g/mL [Quantitative Concept]
   770   C1979839:75 g [Quantitative Concept]
   767 E C1637390:mL/g [Quantitative Concept]
   744   C0086045:Concentration [Mental Process]
   744   C0205088:Final [Temporal Concept]
   744   C0439267:g% [Quantitative Concept]
   744   C0439526:/mL [Quantitative Concept]
   744   C1273517:used [Finding]
   744   C1446561:Concentration [Quantitative Concept]
   744   C1546485:Final [Idea or Concept]
   711 E C0042153:use [Functional Concept]
   711 E C0457083:Use [Functional Concept]
   711 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.93: Mouse anti-HA antibodies were used at the 1/1000 final dilution. 

Phrase: "Mouse anti-HA antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   875   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "used at the 1/1000 final dilution."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C0079240:Dilution [Laboratory Procedure]
   748   C0205088:Final [Temporal Concept]
   748   C1273517:used [Finding]
   748   C1546485:Final [Idea or Concept]
   748   C1948037:Dilution [Functional Concept]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.94: In double labeling experiments, a rabbit antibovine catalase antibody (1/200 dilution; Biodesign, Kennebunkport, ME) or a guinea pig anti-rat peroxisomal membrane protein (PMP70) antibody (1/200 dilution) were used simultaneously with the specific mouse antibody against human IDE, 31H7, or the mouse anti-HA antibody. 

Phrase: "In double labeling experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "a rabbit antibovine catalase antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1/200 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0079240:Dilution [Laboratory Procedure]
   827   C1948037:Dilution [Functional Concept]

Phrase: "; Biodesign,"

Phrase: "Kennebunkport,"

Phrase: "ME)"

Phrase: "or"

Phrase: "a guinea pig anti-rat peroxisomal membrane protein"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   845   C1335665:Rat Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1179904:Peroxisomal membrane [Cell Component]
   795   C0025255:Membrane [Tissue]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0596901:Membrane [Cell Component]
   795   C1706182:Membrane [Manufactured Object]
   795   C3546463:peroxisomal [Cell Component]
   724 E C0205287:Membranous [Qualitative Concept]
   724 E C0752063:Peroxisomes [Cell Component]
   724 E C2984308:Peroxisome [Functional Concept]

Phrase: "(PMP70"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412090:PMP70 [Gene or Genome]

Phrase: ")"

Phrase: "antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1/200 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0079240:Dilution [Laboratory Procedure]
   827   C1948037:Dilution [Functional Concept]

Phrase: ")"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "simultaneously with the specific mouse antibody"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   783   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0205369:Specific [Qualitative Concept]
   753   C0521115:simultaneously [Temporal Concept]
   753   C1552740:specific [Intellectual Product]

Phrase: "against human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "31H7,"

Phrase: "or"

Phrase: "the mouse anti-HA antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.95: The secondary antibodies were Cy3-conjugated donkey to rabbit or guinea pig IgG and fluorescein-conjugated donkey antimouse (Jackson Immunoresearch Laboratories, Inc., West Grove, PA). 

Phrase: "The secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "Cy3-conjugated donkey to rabbit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0324145:Donkey [Mammal]

Phrase: "or"

Phrase: "guinea pig IgG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0085979:Guinea pig, NOS [Mammal]
   734   C0999699:Guinea-pig [Mammal]

Phrase: "and"

Phrase: "fluorescein-conjugated donkey"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0324145:Donkey [Mammal]

Phrase: "antimouse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979849:Antimouse [Immunologic Factor]

Phrase: "(Jackson Immunoresearch Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: "Inc.,"

Phrase: "West Grove,"

Phrase: "PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.96: COS cells transfected with the pCMVo vector alone were used as a negative control. 

Phrase: "COS cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0376702:COS Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with the pCMVo vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "were"

Phrase: "used as a negative control."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   806   C1639518:% negative control [Quantitative Concept]
   806   C1947986:Negative Control [Conceptual Entity]
   760   C0205160:Negative [Qualitative Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1273517:used [Finding]
   760   C1513916:Negative [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.97: Cells were photographed on the same plane of focus with a Leitz (Wetzlar, Germany) Aristoplan microscope using appropriate filters for Cy3 and fluorescein.  

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "photographed on the same plane of focus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205234:Focus [Spatial Concept]
   748   C0444660:Plane [Spatial Concept]
   748   C0445247:Same [Qualitative Concept]
   748   C1285542:focus [Functional Concept]
   714   C0441468:photograph [Manufactured Object]

Phrase: "with a Leitz"

Phrase: "(Wetzlar,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "Aristoplan microscope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0181839:Microscope [Medical Device]
   861   C1706379:Microscope [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "appropriate filters for Cy3"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   770   C0180860:Filters [Manufactured Object]
   737 E C0581406:Filter [Medical Device]
   737 E C1522664:Filter [Intellectual Product]
   737 E C1704449:Filter [Conceptual Entity]
   737 E C1704684:Filter [Medical Device]
   737 E C1875155:FILTER [Medical Device]

Phrase: "and"

Phrase: "fluorescein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.98: Results Top Abstract Introduction Materials and Methods Results Discussion References  Generation of peroxisomal targeting mutants Three mutations of the A-K-L peroxisomal targeting signal of human IDE were generated by site-specific mutagenesis using primer-directed DNA polymerization on a plasmid template. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Generation of peroxisomal targeting mutants Three mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079411:Generation [Temporal Concept]
   748   C3146294:Generation [Activity]

Phrase: "of the A-K-L peroxisomal targeting signal"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   799   C1521840:Targeting [Functional Concept]
   799   C1710082:Signal [Phenomenon or Process]
   799   C3546463:peroxisomal [Cell Component]
   766 E C2986546:TARGET [Diagnostic Procedure]
   727 E C0752063:Peroxisomes [Cell Component]
   727 E C2984308:Peroxisome [Functional Concept]

Phrase: "of human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "generated by site-specific mutagenesis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0079870:Site-Specific Mutagenesis [Genetic Function]
   806   C0449604:site specific [Spatial Concept]
   760   C0079866:Mutagenesis [Molecular Function]
   760   C0205145:Site [Spatial Concept]
   760   C0205369:Specific [Qualitative Concept]
   760   C1515974:Site [Body Location or Region]
   760   C1552740:specific [Intellectual Product]
   760   C2825164:Site [Spatial Concept]
   760   C3146294:Generated [Activity]
   760   C3146302:Mutagenesis [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primer-directed DNA polymerization on a plasmid template."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0314672:Polymerisation [Phenomenon or Process]
Processing 00000000.tx.99: A pCMVo expression vector containing the 3.4-kb cDNA of human IDE was used as the template. 

Phrase: "A pCMVo expression vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the 3.4-kb cDNA of human"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "used as the template."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0728990:TEMPLATE [Medical Device]
   770   C1273517:used [Finding]
   770   C1514575:Template [Conceptual Entity]
   770   C1705542:Template [Idea or Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.100: Specifically, one mutation was made that changed the alanine to leucine (AL.pts), one mutation was made that changed the leucine to valine (LV.pts), and one mutation was made that deleted the entire tripeptide (DEL.pts.) 

Phrase: "Specifically,"

Phrase: "one mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "that"

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "the alanine to leucine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C2736422:Leucine/Alanine [Amino Acid, Peptide, or Protein]
   770   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(AL.pts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "one mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "that"

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "the leucine to valine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(LV.pts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "one mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "that"

Phrase: "deleted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]

Phrase: "the entire tripeptide"

Phrase: "(DEL.pts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]

Phrase: ")"
Processing 00000000.tx.101: Previous studies have demonstrated that these mutations of the peroxisomal targeting signal abolish the import of peroxisomal proteins transiently expressed in CV-1 monkey kidney cells (25). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "these mutations of the peroxisomal targeting signal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "abolish"

Phrase: "the import of peroxisomal proteins transiently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1326471:Protein Import [Cell Function]
   753   C0699788:Import [Occupational Activity]

Phrase: "expressed in CV-1 monkey kidney cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   778   C0111339:CV-1 [Antibiotic,Organic Chemical]
   774   C0553257:cells kidney [Cell]
   748   C0007634:Cells [Cell]
   748   C0022646:Kidney [Body Part, Organ, or Organ Component]
   748   C0026447:Monkey [Mammal]
   748   C0227665:kidney [Body Part, Organ, or Organ Component]
   748   C1278978:Kidney [Body Part, Organ, or Organ Component]
   748   C1514845:KIDNEY [Tissue]
   748   C3282337:Cells [Cell]
   748   C3538987:CV [Idea or Concept]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.102: Expression of wild-type IDE and peroxisomal targeting mutants in transfected COS cells We have previously used this pCMVo vector, which has a cytomegalovirus promoter and the SV40 origin, to transiently express IDE in COS cells. 

Phrase: "Expression of wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "peroxisomal targeting mutants in transfected COS cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this pCMVo vector,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "which"

Phrase: "has"

Phrase: "a cytomegalovirus promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the SV40 origin,"
Meta Candidates (Total=16; Excluded=13; Pruned=0; Remaining=3)
   861   C0079946:origin [Classification]
   861   C0439659:Origin [Temporal Concept]
   861   C1550512:origin [Intellectual Product]
   805 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   805 E C0314603:Genetic [Functional Concept]
   789 E C0205313:Original [Idea or Concept]
   789 E C2347409:Original [Occupational Activity]
   777 E C0005615:Birth [Organism Function]
   777 E C0035150:Reproduction [Organism Function]
   777 E C1550722:birth [Idea or Concept]
   777 E C3245487:birth [Intellectual Product]
   761 E C0454729:Natal [Geographic Area]
   761 E C0559522:Genital [Body System]
   761 E C0598240:originality [Mental Process]
   761 E C1546649:Genital [Intellectual Product]
   761 E C1550642:Genital [Body Substance]

Phrase: "to transiently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in COS cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0376702:COS Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.103: Those experiments demonstrated that overexpression of IDE results in increased cellular degradation of insulin (13). 

Phrase: "Those experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "demonstrated"

Phrase: "that overexpression of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514559:Overexpression [Genetic Function]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "results in increased cellular degradation of insulin"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   778   C1523935:cellular degradation [Cell Function]
   774   C0020459:increased insulin [Disease or Syndrome]
   774   C3547574:insulin degradation [Molecular Function]
   748   C0007634:Cellular [Cell]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0178539:Cellular [Functional Concept]
   748   C0205217:Increased [Quantitative Concept]
   748   C0243125:degradation [Functional Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0699900:Degradation [Organism Function]
   748   C1274040:Result [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1546471:Result [Idea or Concept]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C2825142:Result [Finding]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.104: In the present experiments, wild-type and mutant enzymes were transiently expressed in COS monkey kidney cells by transfection of pCMVo vectors containing the appropriate cDNA. 

Phrase: "In the present experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "mutant enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "expressed in COS monkey kidney cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   783   C0376702:COS Cells [Cell]
   783   C0553257:cells kidney [Cell]
   753   C0007634:Cells [Cell]
   753   C0022646:Kidney [Body Part, Organ, or Organ Component]
   753   C0026447:Monkey [Mammal]
   753   C0227665:kidney [Body Part, Organ, or Organ Component]
   753   C0454802:Cos [Geographic Area]
   753   C1278978:Kidney [Body Part, Organ, or Organ Component]
   753   C1514845:KIDNEY [Tissue]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "by transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "of pCMVo vectors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vectors [Spatial Concept]
   827 E C1705099:Vector [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the appropriate cDNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.105: The pCMVo vector alone was used as a negative control. 

Phrase: "The pCMVo vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "was"

Phrase: "used as a negative control."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   806   C1639518:% negative control [Quantitative Concept]
   806   C1947986:Negative Control [Conceptual Entity]
   760   C0205160:Negative [Qualitative Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1273517:used [Finding]
   760   C1513916:Negative [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.106: Western blotting with anti-IDE antibody (2BS antibody) was used to confirm expression of the transfected genes. 

Phrase: "Western blotting with anti-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "IDE antibody"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   875   C0021644:Insulin antibody [Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(2BS antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "expression of the transfected genes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.107: An immunoreactive band at the correct molecular weight for IDE (110,000) was increased severalfold over the pCMVo control in extracts of cells transfected with wild-type IDE1 (wtIDE), AL.pts, or LV.pts (Fig. 1). 

Phrase: "An immunoreactive band at the correct molecular weight"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0175723:Band [Medical Device]
   744   C0439645:Band [Spatial Concept]
   744   C1521913:band [Cell Component]

Phrase: "for"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(110,000"

Phrase: ")"

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "severalfold over the pCMVo control"

Phrase: "in extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "of cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with wild-type IDE1 (wtIDE),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "AL.pts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]

Phrase: "or"

Phrase: "LV.pts (Fig. 1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0023128:LV [Geographic Area]
   812   C0349966:Fig [Food]
   812   C0731033:LV [Organic Chemical,Pharmacologic Substance,Vitamin]
   812   C1337208:FIG [Food]
   812   C1419129:PTS [Gene or Genome]
   812   C1881413:LV [Chemical Viewed Structurally]
   812   C2698747:PTS [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.108: Interestingly, the deletion mutant shows a lower molecular weight protein that is reduced in amount relative to the other overexpressed IDEs. 

Phrase: "Interestingly,"

Phrase: "the deletion mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a lower molecular weight protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "is"

Phrase: "reduced in amount"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0392756:Reduced [Qualitative Concept]
   790   C1265611:Amount [Quantitative Concept]

Phrase: "relative to the"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "other overexpressed IDEs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0328104:Ide [Fish]
   861   C1415875:IDE [Gene or Genome]
   861   C2826366:IDE [Idea or Concept]
Processing 00000000.tx.109: This band is smaller than that which we occasionally see at 100,000, and which has been determined to represent a degradation product of IDE. 

Phrase: "This band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175723:Band [Medical Device]
  1000   C0439645:Band [Spatial Concept]
  1000   C1521913:band [Cell Component]

Phrase: "is"

Phrase: "smaller than that"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0547044:Smaller [Qualitative Concept]
   790   C0700321:Smaller [Quantitative Concept]

Phrase: "which we occasionally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998882:Occasionally [Temporal Concept]

Phrase: "see at 100,000,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0042789:see [Organism Function]
   770   C1947903:See [Activity]

Phrase: "and"

Phrase: "which"

Phrase: "has"

Phrase: "been"

Phrase: "determined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a degradation product of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1514468:product [Entity]
   770   C1704444:Product [Quantitative Concept]

Phrase: "IDE."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.110: The faint band at 110 kDa in the DEL.pts lane is endogenous IDE and is identical in size and amount to the band in the pCMVo lane. 

Phrase: "The faint band at 110 kDa"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0175723:Band [Medical Device]
   753   C0439645:Band [Spatial Concept]
   753   C1521913:band [Cell Component]

Phrase: "in the DEL.pts lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "is"

Phrase: "endogenous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205227:Endogenous [Functional Concept]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "is"

Phrase: "identical in size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "and"

Phrase: "amount to the band"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "in the pCMVo lane."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]
Processing 00000000.tx.111: These results suggest that the AL.pts and LV.pts mutants are not altered in stability, but that the deletion mutation appears to affect the stability of the protein. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the AL.pts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]

Phrase: "and"

Phrase: "LV.pts mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered in stability,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205360:Stability [Qualitative Concept]
   790   C0392747:Altered [Functional Concept]
   790   C2347098:Stability [Qualitative Concept]
   718 E C1547311:Stable [Intellectual Product]

Phrase: "but"

Phrase: "that"

Phrase: "the deletion mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1511760:Deletion Mutation [Genetic Function]
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the stability of the protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C2350440:Protein Stability [Qualitative Concept]
   760   C0205360:Stability [Qualitative Concept]
   760   C2347098:Stability [Qualitative Concept]
Processing 00000000.tx.112: A similar result was obtained with an independent clone expressing the deletion mutant, indicating that the result is not an artifact of clonal variation (data not shown.) 

Phrase: "A similar result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1274040:Result [Functional Concept]
   861   C1546471:Result [Idea or Concept]
   861   C2825142:Result [Finding]

Phrase: "was"

Phrase: "obtained with an independent clone"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0009013:Clone [Cell]
   760   C0085862:Independent [Idea or Concept]
   760   C1299583:Independent [Finding]
   760   C1301820:Obtained [Functional Concept]
   760   C1522642:Clone [Tissue]
   726 E C1706701:Obtain [Activity]

Phrase: "expressing"

Phrase: "the deletion mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "indicating"

Phrase: "that"

Phrase: "the result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "an artifact of clonal variation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0085089:Artefact [Human-caused Phenomenon or Process]
   760   C1879740:ARTIFACT [Phenomenon or Process]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"
Processing 00000000.tx.113: View larger version (52K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(52K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.114: Production of immunoreactive protein in COS cells transfected with wtIDE and peroxisomal targeting mutants. 

Phrase: "Production of immunoreactive protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "in COS cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0376702:COS Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with wtIDE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "peroxisomal targeting mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.115: Extracts from transfected cells were prepared, electrophoresed, and Western blotted with antiserum 2BS as described under Materials and Methods. 

Phrase: "Extracts from transfected cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0007592:Cell Extracts [Cell Component]
   737   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: ","

Phrase: "electrophoresed,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013855:electrophorese [Laboratory Procedure]

Phrase: "and"

Phrase: "Western"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:Western [Spatial Concept]

Phrase: "blotted with antiserum 2BS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "described under Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.116: Fifty micrograms were used for each extract. 

Phrase: "Fifty micrograms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439211:microgram [Quantitative Concept]

Phrase: "were"

Phrase: "used for each extract."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1273517:used [Finding]
   770   C2828366:Extract [Substance]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.117: Bands were visualized by autoradiography of 125I-protein A. 

Phrase: "Bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "visualized by autoradiography of 125I-protein A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0004400:Autoradiography [Laboratory Procedure]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0234621:Visualized [Functional Concept]
Processing 00000000.tx.118: Arrows with numbers (in kDa) indicate the position of prestained molecular mass markers.  

Phrase: "Arrows with numbers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0336721:arrows [Manufactured Object]

Phrase: "("

Phrase: "in kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1532717:kDa [Quantitative Concept]

Phrase: "indicate"

Phrase: "the position of prestained molecular mass markers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0733755:Position [Spatial Concept]
Processing 00000000.tx.119: Insulin degrading activity and binding ability of peroxisomal targeting mutants We have previously shown that transient overexpression of wtIDE in COS cells results in increased degradation of insulin via an intracellular pathway (13). 

Phrase: "Insulin degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   913   C1145751:insulin activity [Molecular Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1561536:*Activity [Idea or Concept]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "binding ability of peroxisomal targeting mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that transient overexpression of wtIDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514559:Overexpression [Genetic Function]

Phrase: "in COS cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0376702:COS Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "results in increased degradation of insulin"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   783   C0020459:increased insulin [Disease or Syndrome]
   783   C3547574:insulin degradation [Molecular Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205217:Increased [Quantitative Concept]
   753   C0243125:degradation [Functional Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0699900:Degradation [Organism Function]
   753   C1274040:Result [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1546471:Result [Idea or Concept]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C2825142:Result [Finding]

Phrase: "via an intracellular pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.120: To determine whether the peroxisomal A-K-L targeting signal is required for IDE to degrade insulin, we measured the ability of mutant-transfected COS cells to hydrolyze cellular insulin relative to control cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the peroxisomal A-K-L targeting signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1710082:Signal [Phenomenon or Process]

Phrase: "is"

Phrase: "required for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1514873:Required [Functional Concept]

Phrase: "IDE to"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "degrade"

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the ability of mutant-transfected COS cells to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0085732:Ability [Organism Attribute]

Phrase: "hydrolyze"

Phrase: "cellular insulin relative to control cells."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   859   C0030281:Insulin Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C0243148:control [Qualitative Concept]
   799   C1550141:Control [Substance]
   799   C1882979:Control [Conceptual Entity]
   799   C2587213:Control [Functional Concept]
   799   C3274648:Control [Qualitative Concept]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.121: Cells were incubated in binding buffer for 30 min and then switched to fresh buffer containing 100 pM 125I-insulin. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated in binding buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "switched to fresh buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0443224:Fresh [Qualitative Concept]
   770   C2827486:Fresh [Body Substance]
   737   C1707719:Switch [Manufactured Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "100 pM 125I-insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.122: Degradation was assayed as described in Materials and Methods. 

Phrase: "Degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.123: We observed a 2- to 3-fold increase in the rate of cellular degradation of insulin in cells transfected with wtIDE, as compared with those transfected with vector alone (Fig. 2). 

Phrase: "We"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a 2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "to 3-fold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:Increase [Functional Concept]

Phrase: "in the rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871208:Rate [Activity]
  1000   C1521828:Rate [Quantitative Concept]

Phrase: "of cellular degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1523935:cellular degradation [Cell Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with wtIDE,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "as"

Phrase: "compared with those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "transfected with vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0442335:Vector [Spatial Concept]
   790   C1705099:Vector [Idea or Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.124: While both AL.pts and LV.pts increased insulin degradation to the same extent as the wild-type enzyme, the deletion mutant did not increase the rate of insulin degradation above that seen with vector alone. 

Phrase: "While"

Phrase: "both AL.pts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]

Phrase: "and"

Phrase: "LV.pts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "insulin degradation to the same extent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C3547574:insulin degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "as the wild-type enzyme,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "the deletion mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the rate of insulin degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "above that"

Phrase: "seen with vector"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0205397:Seen [Qualitative Concept]
   790   C0442335:Vector [Spatial Concept]
   790   C1705099:Vector [Idea or Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.125: Because the stress of transfection can result in some nonspecific leakage of proteins into the cell medium, we assayed conditioned medium to determine whether AL.pts and LV.pts are really degrading insulin intracellularly. 

Phrase: "Because"

Phrase: "the stress of transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0038435:Stress [Finding]

Phrase: "can"

Phrase: "result in some nonspecific leakage of proteins"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0015376:Leakage [Pathologic Function]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205370:Non-specific [Qualitative Concept]
   748   C0750540:Nonspecific [Idea or Concept]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "into the cell medium,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "we"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "conditioned medium to"
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   901   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   827   C0009458:Medium [Intellectual Product]
   827   C0009647:Conditioned [Mental Process]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]
   755 E C0012634:condition [Disease or Syndrome]
   755 E C0348080:Condition [Qualitative Concept]
   755 E C1705253:Condition [Conceptual Entity]
   727 E C1701901:Conditional [Qualitative Concept]
   727 E C1963686:Conditional [Functional Concept]
   711 E C1519605:Conditionality [Conceptual Entity]

Phrase: "determine"

Phrase: "whether"

Phrase: "AL.pts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]

Phrase: "and"

Phrase: "LV.pts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]

Phrase: "are"

Phrase: "really"

Phrase: "degrading"

Phrase: "insulin intracellularly."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.126: We collected conditioned medium (binding buffer without labeled insulin) that had been incubated with the cells for 30 min and assayed it for insulin-degrading activity in parallel to the transfected cells (Fig. 3). 

Phrase: "We"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "conditioned medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "(binding buffer without labeled insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")"

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "incubated with the cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "it for insulin-degrading activity"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   797   C1145751:insulin activity [Molecular Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1561536:*Activity [Idea or Concept]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in parallel to the transfected cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0150312:In [Quantitative Concept]
   753   C0332285:In [Spatial Concept]
   753   C2348042:Parallel [Qualitative Concept]
   753   C2826345:PARALLEL [Research Activity]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.127: Insulin degradation in the conditioned medium did not account for more than 1/5 of the total insulin degradation and was comparable with that observed in cells expressing wtIDE. 

Phrase: "Insulin degradation in the conditioned medium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C3547574:insulin degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "account for more"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1551359:account [Idea or Concept]
   790   C2741673:Account # [Clinical Attribute]
   790   C2981730:Account [Classification]

Phrase: "than 1/5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "of the total insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C3547574:insulin degradation [Molecular Function]
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "was"

Phrase: "comparable with that"

Phrase: "observed in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1441672:Observed [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "wtIDE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.128: These results indicate that two mutations, AL.pts and LV.pts, do not affect the ability of the enzyme to degrade insulin in cells. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that two mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "AL.pts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]

Phrase: "and"

Phrase: "LV.pts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the ability of the enzyme to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "degrade"

Phrase: "insulin in cells."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   841   C0030281:Insulin Cell [Cell]
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.129: View larger version (27K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.130: Degradation of insulin by COS cells transfected with wtIDE or peroxisomal targeting mutants. 

Phrase: "Degradation of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C3547574:insulin degradation [Molecular Function]
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "by COS cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0376702:COS Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with wtIDE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "peroxisomal targeting mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.131: COS cells were transfected with pCMVo, wtIDE, and the three mutants of the peroxisomal targeting signal. 

Phrase: "COS cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0376702:COS Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with pCMVo,"

Phrase: "wtIDE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "the three mutants of the peroxisomal targeting signal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.132: Forty hours after transfection, cells were preincubated for 30 min in binding buffer and then switched to fresh binding buffer containing 100 pM 125I-insulin. 

Phrase: "Forty hours after transfection,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439227:hours [Temporal Concept]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "preincubated for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "in binding buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "switched to fresh binding buffer"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0243122:binding [Functional Concept]
   760   C0443224:Fresh [Qualitative Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C2827486:Fresh [Body Substance]
   726   C1707719:Switch [Manufactured Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "100 pM 125I-insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.133: Cells were incubated for the indicated times and the extent of insulin degradation was quantitated by trichloroacetic acid-precipitation as described in Materials and Methods. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for the indicated times"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1444656:Indicated [Finding]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "the extent of insulin degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439792:Extent [Spatial Concept]

Phrase: "was"

Phrase: "quantitated by trichloroacetic acid-precipitation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0032931:Precipitation [Natural Phenomenon or Process]
   760   C0032932:Precipitation [Molecular Function]
   760   C0202406:Acid [Laboratory Procedure]
   760   C1642401:% precipitation [Quantitative Concept]
   760   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.134: The results are shown as means  SD of triplicate determinations. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown as means  SD of triplicate determinations."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   748   C0205174:Triplicate [Quantitative Concept]
   748   C0680730:determinations [Governmental or Regulatory Activity]
   748   C1704970:Means [Conceptual Entity]
   714 E C0444504:Mean [Quantitative Concept]
   714 E C1148554:determination [Laboratory Procedure]
   714   C1547282:Show [Intellectual Product]
   714 E C2347634:Mean [Quantitative Concept]
   714 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.135: Where not shown, the error bars are smaller than the plot symbol.  

Phrase: "Where"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ","

Phrase: "the error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "are"

Phrase: "smaller than the plot symbol."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0547044:Smaller [Qualitative Concept]
   760   C0700321:Smaller [Quantitative Concept]
Processing 00000000.tx.136: View larger version (28K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.137: Degradation of insulin in conditioned medium from COS cells transfected with wtIDE or peroxisomal targeting mutants. 

Phrase: "Degradation of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C3547574:insulin degradation [Molecular Function]
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "in conditioned medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "from COS cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0376702:COS Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with wtIDE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "peroxisomal targeting mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.138: Cells were transfected with pCMVo, wtIDE, or with one of three peroxisomal targeting mutants of IDE. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with pCMVo,"

Phrase: "wtIDE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "or with one of three peroxisomal targeting mutants of"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   742   C0205447:One [Quantitative Concept]
   742   C0205449:Three [Quantitative Concept]
   742   C0596988:mutants [Cell or Molecular Dysfunction]
   742   C1521840:Targeting [Functional Concept]
   742   C3546463:peroxisomal [Cell Component]
   708 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "IDE."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.139: Before assaying cellular degradation, cells were preincubated with binding buffer for 30 min. 

Phrase: "Before"

Phrase: "assaying"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "cellular degradation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1523935:cellular degradation [Cell Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "preincubated with binding buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.140: This buffer was then transferred to a fresh plate and 100 pM 125I-insulin was added. 

Phrase: "This buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "transferred to a fresh plate"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0005971:Plate [Medical Device]
   760   C0348011:transferred [Functional Concept]
   760   C0443224:Fresh [Qualitative Concept]
   760   C1139930:plate [Medical Device]
   760   C2827486:Fresh [Body Substance]
   760   C3537155:Plate [Manufactured Object]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "100 pM 125I-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.141: Degradation was measured at the times indicated. 

Phrase: "Degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "measured at the times"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0040223:times [Temporal Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C1632851:Times [Quantitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.142: Results are shown as means  SD of triplicate determinations. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown as means  SD of triplicate determinations."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   748   C0205174:Triplicate [Quantitative Concept]
   748   C0680730:determinations [Governmental or Regulatory Activity]
   748   C1704970:Means [Conceptual Entity]
   714 E C0444504:Mean [Quantitative Concept]
   714 E C1148554:determination [Laboratory Procedure]
   714   C1547282:Show [Intellectual Product]
   714 E C2347634:Mean [Quantitative Concept]
   714 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.143: Where not shown, the error bars are smaller than the plot symbol.  

Phrase: "Where"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ","

Phrase: "the error bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "are"

Phrase: "smaller than the plot symbol."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0547044:Smaller [Qualitative Concept]
   760   C0700321:Smaller [Quantitative Concept]
Processing 00000000.tx.144: We also assayed the ability of all three mutants to catalyze the in vitro degradation of insulin. 

Phrase: "We also"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "the ability of all three mutants to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0085732:Ability [Organism Attribute]

Phrase: "catalyze"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007382:catalyse [Natural Phenomenon or Process]

Phrase: "the in vitro degradation of insulin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C3547574:insulin degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]
Processing 00000000.tx.145: Insulin-degrading activity was increased 4- to 6-fold in extracts from cells transfected with wtIDE, AL.pts, or LV.pts (Fig. 4). 

Phrase: "Insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   913   C1145751:insulin activity [Molecular Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1561536:*Activity [Idea or Concept]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "4-"

Phrase: "to 6-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "in extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "from cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with wtIDE,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "AL.pts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]

Phrase: "or"

Phrase: "LV.pts (Fig. 4"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0023128:LV [Geographic Area]
   812   C0349966:Fig [Food]
   812   C0731033:LV [Organic Chemical,Pharmacologic Substance,Vitamin]
   812   C1337208:FIG [Food]
   812   C1419129:PTS [Gene or Genome]
   812   C1881413:LV [Chemical Viewed Structurally]
   812   C2698747:PTS [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.146: In contrast, extracts from cells transfected with DEL.pts showed the same specific activity as those from cells transfected with pCMVo. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "extracts from cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   841   C0007592:Cell Extracts [Cell Component]
   790   C0007634:Cells [Cell]
   790   C2828366:Extract [Substance]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with DEL.pts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0008628:del [Cell or Molecular Dysfunction]
   770   C1419129:PTS [Gene or Genome]
   770   C2698747:PTS [Intellectual Product]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the same specific activity as those from cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0205177:Activity [Functional Concept]
   744   C0205369:Specific [Qualitative Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1552740:specific [Intellectual Product]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "transfected with pCMVo."
Processing 00000000.tx.147: These results demonstrate that deletion of the terminal tripeptide results in loss of enzyme activity, whereas altering one amino acid in the conserved peroxisomal targeting tripeptide had no effect on the catalytic activity of the mutant proteins. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that deletion of the terminal tripeptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "results in loss of enzyme activity,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0243102:enzyme activity [Molecular Function]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1274040:Result [Functional Concept]
   753   C1517945:Loss [Quantitative Concept]
   753   C1546471:Result [Idea or Concept]
   753   C1561536:*Activity [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "whereas"

Phrase: "altering one amino acid in the conserved peroxisomal targeting tripeptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C2917660:Amino Acid [Pharmacologic Substance]
   739   C0001128:Acid [Chemical]
   739   C0202406:Acid [Laboratory Procedure]

Phrase: "had"

Phrase: "no effect on the catalytic activity of the mutant proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1301751:No effect [Qualitative Concept]
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.148: View larger version (21K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.149: Insulin-degrading activity in extracts from cells transfected with wtIDE or peroxisomal targeting mutants of IDE. 

Phrase: "Insulin-degrading activity in extracts"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   797   C1145751:insulin activity [Molecular Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1561536:*Activity [Idea or Concept]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "from cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with wtIDE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "peroxisomal targeting mutants of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "IDE."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.150: Extracts from transfected cells were prepared and assayed for insulin-degrading activity as described under Materials and Methods using 1 g of total cell extract per assay. 

Phrase: "Extracts from transfected cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0007592:Cell Extracts [Cell Component]
   737   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "assayed for insulin-degrading activity"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   797   C1145751:insulin activity [Molecular Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1561536:*Activity [Idea or Concept]
   760   C1579433:Insulin [Pharmacologic Substance]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "as"

Phrase: "described under Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "1 g of total cell extract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0524983:G cell [Cell]
   783   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   753   C0439267:g% [Quantitative Concept]

Phrase: "per assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.151: Results are shown as means  SD of triplicate determinations.  

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown as means  SD of triplicate determinations."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   748   C0205174:Triplicate [Quantitative Concept]
   748   C0680730:determinations [Governmental or Regulatory Activity]
   748   C1704970:Means [Conceptual Entity]
   714 E C0444504:Mean [Quantitative Concept]
   714 E C1148554:determination [Laboratory Procedure]
   714   C1547282:Show [Intellectual Product]
   714 E C2347634:Mean [Quantitative Concept]
   714 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.152: Affinity labeling with 125I-insulin was used to assess the ability of the mutants to bind this substrate. 

Phrase: "Affinity labeling with 125I-insulin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0178463:affinity labeling [Laboratory or Test Result]
   760   C1167624:Labeling [Mental Process]
   760   C1947902:Labeling [Manufactured Object]
   760   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the ability of the mutants to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "this substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.153: Cell extracts from each transfectant were incubated with 125I-insulin at 0 C and covalently cross-linked using disuccinimidyl suberate. 

Phrase: "Cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "extracts from each transfectant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "incubated with 125I-insulin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "at 0 C"

Phrase: "and"

Phrase: "covalently"

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "disuccinimidyl suberate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0058479:disuccinimidyl suberate [Organic Chemical,Pharmacologic Substance]
   861   C0947344:Suberate [Organic Chemical]
Processing 00000000.tx.154: As expected, extracts of cells transfected with wild-type IDE had increased labeling as compared with extracts from the pCMVo control (Fig. 5). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "extracts of cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   841   C0007592:Cell Extracts [Cell Component]
   790   C0007634:Cells [Cell]
   790   C2828366:Extract [Substance]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "had"

Phrase: "increased labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "as"

Phrase: "compared with extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1707455:Compared [Activity]
   756   C2828366:Extract [Substance]

Phrase: "from the pCMVo control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.155: Extracts from the AL.pts and LV.pts mutants also showed an increase in cross-linking to 125I-insulin, suggesting that the sequence A-K-L is not directly involved in binding of substrate. 

Phrase: "Extracts from the AL.pts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "LV.pts mutants also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an increase in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0442805:Increase [Functional Concept]

Phrase: "cross-linking to 125I-insulin,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332220:Cross-linking [Functional Concept]
   790 E C0178576:Cross link [Natural Phenomenon or Process]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C2828360:Cross [Conceptual Entity]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the sequence A-K-L"

Phrase: "is"

Phrase: "not directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Not [Functional Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "involved in binding of substrate."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1314939:Involved [Functional Concept]
   760   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.156: The DEL.pts mutant did not cross-link to insulin at all, indicating that the protein visualized by Western blotting (Fig. 1), although close in size to wild-type enzyme, is incapable of binding insulin. 

Phrase: "The DEL.pts mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "did"

Phrase: "not cross-link to insulin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0178576:Cross link [Natural Phenomenon or Process]
   806   C0332220:cross link [Functional Concept]
   760   C1517892:Link [Intellectual Product]
   760   C1704666:Link [Intellectual Product]
   760   C2828360:Cross [Conceptual Entity]

Phrase: "at all,"

Phrase: "indicating"

Phrase: "that"

Phrase: "the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "visualized by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0234621:Visualized [Functional Concept]
   770   C1705493:Western [Spatial Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "close in size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0587267:Close [Functional Concept]

Phrase: "to wild-type enzyme,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "is"

Phrase: "incapable of binding insulin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1550518:incapable [Idea or Concept]
Processing 00000000.tx.157: Because this protein appears to be greater than 90 kDa by comparison with prestained molecular weight markers, it seems likely that improper folding of the protein has resulted in loss of ability to recognize its substrate. 

Phrase: "Because"

Phrase: "this protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "greater than 90 kDa"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0439093:Greater Than [Quantitative Concept]
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "by comparison with prestained molecular weight markers,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0005516:molecular markers [Clinical Attribute]
           Marker

Phrase: "it"

Phrase: "seems"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that improper folding of the protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0162847:folding protein [Molecular Function]
   753   C0185026:Folding [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "resulted in loss of ability to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0085732:Ability [Organism Attribute]
   753   C1517945:Loss [Quantitative Concept]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "recognize"

Phrase: "its substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.158: View larger version (32K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(32K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.159: Cross-linking of 125I-insulin to peroxisomal targeting mutants. 

Phrase: "Cross-linking of 125I-insulin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332220:Cross-linking [Functional Concept]
   790 E C0178576:Cross link [Natural Phenomenon or Process]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C2828360:Cross [Conceptual Entity]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "to peroxisomal targeting mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.160: Extracts were prepared and affinity-labeled in the presence of 0.5 nM 125I-insulin with or without and excess of unlabeled insulin. 

Phrase: "Extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "affinity-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "labeled in the presence of 0.5 nM 125I-insulin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0444499:0/5 [Quantitative Concept]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0312860:NM [Cell Function]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
   739   C1708632:Labeled [Qualitative Concept]
   706 E C0181496:Label [Manufactured Object]
   706 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "with"

Phrase: "or without"

Phrase: "and"

Phrase: "excess of unlabeled insulin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1979886:Excess [Qualitative Concept]
Processing 00000000.tx.161: Cross-linked products were separated by SDS-gel electrophoresis and visualized by autoradiography. 

Phrase: "Cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "separated by SDS-gel electrophoresis"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0596607:Gel Electrophoresis [Laboratory Procedure]
   797 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   760   C0013855:Electrophoresis [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "visualized by autoradiography."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004400:Autoradiography [Laboratory Procedure]
   790   C0234621:Visualized [Functional Concept]
Processing 00000000.tx.162: The Mr of the observed bands was about 110,000 by comparison with prestained markers.  

Phrase: "The Mr of the observed bands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347167:Mr. [Conceptual Entity]

Phrase: "was"

Phrase: "about 110,000 by comparison with prestained markers."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1707455:Comparison [Activity]
   711   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.163: Immunolocalization of the overexpressed peroxisomal targeting mutant and wild-type IDEs To verify that the three mutations of IDEs peroxisomal targeting signal effectively abolished the import of the protease into peroxisomes, the cellular localization of wild-type and mutant IDEs was determined by immunocytofluorescence and confocal microscopy analysis. 

Phrase: "Immunolocalization of the overexpressed peroxisomal targeting mutant"

Phrase: "and"

Phrase: "wild-type IDEs To"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0328104:Ide [Fish]
   812   C1415875:IDE [Gene or Genome]
   812   C2826366:IDE [Idea or Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "that"

Phrase: "the three mutations of IDEs peroxisomal targeting signal effectively"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0026882:Mutations [Genetic Function]
   708 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "abolished"

Phrase: "the import of the protease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0699788:Import [Occupational Activity]

Phrase: "into peroxisomes,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]

Phrase: "the cellular localization of wild-type"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1660642:cellular localisation [Cell Function]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "mutant IDEs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0328104:Ide [Fish]
   861   C1415875:IDE [Gene or Genome]
   861   C2826366:IDE [Idea or Concept]

Phrase: "was"

Phrase: "determined by immunocytofluorescence"

Phrase: "and"

Phrase: "confocal microscopy analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0242842:Microscopy, Confocal [Laboratory Procedure]
Processing 00000000.tx.164: Figure 6A, which shows immunofluorescent labeling of the LV.pts, illustrates one of the labeling patterns obtained for both single mutants, LV.pts and AL.pts. 

Phrase: "Figure 6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: "which"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "immunofluorescent labeling of the LV.pts,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1167624:Labeling [Mental Process]
   753   C1947902:Labeling [Manufactured Object]
   753   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "illustrates"

Phrase: "one of the labeling patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "obtained for both single mutants,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C0596988:mutants [Cell or Molecular Dysfunction]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "LV.pts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]

Phrase: "and"

Phrase: "AL.pts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]
Processing 00000000.tx.165: In contrast to the punctate labeling of catalase (Fig. 6B), the IDE labeling in these cells was diffuse. 

Phrase: "In contrast to the punctate labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "of catalase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "(Fig. 6B"

Phrase: ")"

Phrase: ","

Phrase: "the"

Phrase: "IDE labeling"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1167624:Labeling [Mental Process]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1947902:Labeling [Manufactured Object]
   804   C2827499:Labeling [Governmental or Regulatory Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "diffuse."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205219:Diffuse [Qualitative Concept]
Processing 00000000.tx.166: Cytosolic staining was observed in all transfected cells. 

Phrase: "Cytosolic staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "observed in all transfected cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C1441672:Observed [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.167: Additionally, nuclear staining could sometimes be observed, but its intensity seemed to vary with the relative level of protein overexpression. 

Phrase: "Additionally,"

Phrase: "nuclear staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "could"

Phrase: "sometimes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998882:Sometimes [Temporal Concept]

Phrase: "be"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "but"

Phrase: "its intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522510:Intensity [Qualitative Concept]

Phrase: "seemed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "vary with the relative level of protein overexpression."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   767   C0428479:Protein level [Laboratory or Test Result]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0080103:Relative [Family Group]
   744   C0205345:Relative [Qualitative Concept]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547039:*Relative [Quantitative Concept]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.168: No colocalization was observed by confocal microscopy between catalase and the peroxisomal targeting mutants of IDE, indicating that IDE was not translocated to the peroxisome. 

Phrase: "No colocalization"

Phrase: "was"

Phrase: "observed by confocal microscopy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0242842:Microscopy, Confocal [Laboratory Procedure]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C1441672:Observed [Functional Concept]

Phrase: "between catalase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "and"

Phrase: "the peroxisomal targeting mutants of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "indicating"

Phrase: "that"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "translocated to the peroxisome."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0752063:Peroxysome [Cell Component]
   770   C2984308:Peroxisome [Functional Concept]
Processing 00000000.tx.169: Similar results were obtained when the peroxisomal membrane protein PMP70 (40) was used as a marker instead of catalase (data not shown). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "when"

Phrase: "the peroxisomal membrane protein PMP70"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1412090:PMP70 [Gene or Genome]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "was"

Phrase: "used as a marker"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0005516:Marker [Clinical Attribute]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "instead of catalase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.170: View larger version (114K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(114K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.171: Micrographs of COS cells transfected with LV.pts, HA-tagged AL.pts, and wtIDE. 

Phrase: "Micrographs of COS cells"

Phrase: "transfected with LV.pts,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0023128:LV [Geographic Area]
   770   C0731033:LV [Organic Chemical,Pharmacologic Substance,Vitamin]
   770   C1419129:PTS [Gene or Genome]
   770   C1881413:LV [Chemical Viewed Structurally]
   770   C2698747:PTS [Intellectual Product]

Phrase: "HA-tagged AL.pts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1419129:PTS [Gene or Genome]
   812   C2698747:PTS [Intellectual Product]

Phrase: "and"

Phrase: "wtIDE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.172: COS cells transfected with either LV.pts (A to C), HA-tagged AL.pts (D to F) or wtIDE (G and H) were fixed and double labeled, with either 31H7 or anti-HA antibodies, and anticatalase or anti-PMP70 antibodies, as described in Materials and Methods. 

Phrase: "COS cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0376702:COS Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with either LV.pts (A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0023128:LV [Geographic Area]
   753   C0731033:LV [Organic Chemical,Pharmacologic Substance,Vitamin]
   753   C1419129:PTS [Gene or Genome]
   753   C1881413:LV [Chemical Viewed Structurally]
   753   C2698747:PTS [Intellectual Product]

Phrase: "to C), HA-tagged AL.pts (D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   895   C0012358:c d [Therapeutic or Preventive Procedure]

Phrase: "to F)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "or"

Phrase: "wtIDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "H)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "were"

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "double labeled,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1708632:Labeled [Qualitative Concept]
   827 E C0181496:Label [Manufactured Object]
   827 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "with either 31H7"

Phrase: "or"

Phrase: "anti-HA antibodies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "anticatalase"

Phrase: "or"

Phrase: "anti-PMP70 antibodies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.173: A, D, and G, Labeling of LV.pts with the anti-IDE antibody 31H7, HA-tagged AL.pts with the anti-HA antibody, and wtIDE with 31H7 respectively. 

Phrase: "A,"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Labeling of LV.pts"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0023128:LV [Geographic Area]
   770   C0731033:LV [Organic Chemical,Pharmacologic Substance,Vitamin]
   770   C1167624:Labeling [Mental Process]
   770   C1419129:PTS [Gene or Genome]
   770   C1881413:LV [Chemical Viewed Structurally]
   770   C1947902:Labeling [Manufactured Object]
   770   C2698747:PTS [Intellectual Product]
   770   C2827499:Labeling [Governmental or Regulatory Activity]
   737 E C0181496:Label [Manufactured Object]

Phrase: "with the anti-"

Phrase: "IDE antibody 31H7,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   861   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   858   C0021644:Insulin antibody [Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C0014445:enzymes [Functional Concept]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "HA-tagged AL.pts with the anti-HA antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1419129:PTS [Gene or Genome]
   742   C2698747:PTS [Intellectual Product]

Phrase: "and"

Phrase: "wtIDE with 31H7 respectively."
Processing 00000000.tx.174: B and E, Immunolabeling of catalase; 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "E,"

Phrase: "Immunolabeling of catalase"

Phrase: ";"
Processing 00000000.tx.175: H, labeling of the peroxisomal membrane protein PMP70. 

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "labeling of the peroxisomal membrane protein PMP70."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   822   C1179904:Membrane of the Peroxisome [Cell Component]
           Peroxisomal membrane
           Membrane of peroxisome
   807   C1179048:Membrane protein of peroxisome [Cell Component]
   778   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0025255:Membrane [Tissue]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0596901:Membrane [Cell Component]
   748   C1167624:Labeling [Mental Process]
   748   C1412090:PMP70 [Gene or Genome]
   748   C1706182:Membrane [Manufactured Object]
   748   C1947902:Labeling [Manufactured Object]
   748   C2827499:Labeling [Governmental or Regulatory Activity]
   748   C3546463:peroxisomal [Cell Component]
   714 E C0181496:Label [Manufactured Object]
Processing 00000000.tx.176: C and F, Nomarski views of the stained cells. 

Phrase: "C"

Phrase: "and"

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Nomarski"

Phrase: "views of the stained cells."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0449911:View [Spatial Concept]
   760   C2986582:Stained [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.177: The bars in C, F, and H correspond to 10 m.  

Phrase: "The bars in C,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1707156:BARS [Gene or Genome]
   770   C3274014:BARS [Intellectual Product]
   770   C3541345:BARS [Intellectual Product]

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "correspond to 10 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.178: To rule out any immunolabeling artifacts, similar experiments were performed on COS cells transfected with an HA epitope-tagged AL.pts construct. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "any immunolabeling artifacts,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0085089:Artifacts [Human-caused Phenomenon or Process]
   861   C0699801:artifacts [Manufactured Object]
   827 E C1879740:ARTIFACT [Phenomenon or Process]

Phrase: "similar experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed on COS cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C0376702:COS Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0454802:Cos [Geographic Area]
   770   C0884358:Performed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "transfected with an HA epitope-tagged AL.pts"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   744   C0003316:Epitope [Immunologic Factor]
   744   C1419129:PTS [Gene or Genome]
   744   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   744   C1708632:Tagged [Qualitative Concept]
   744   C2698747:PTS [Intellectual Product]
   711 E C0037293:Tag [Neoplastic Process]
   711 E C0181496:Tag [Manufactured Object]
   711 E C1710492:TAG [Gene or Genome]

Phrase: "construct."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]
Processing 00000000.tx.179: The HA-tagged mutant of IDE was detected using an antibody specifically directed against the hemagglutinin epitope. 

Phrase: "The HA-tagged mutant of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an antibody specifically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against the hemagglutinin epitope."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0003316:Epitope [Immunologic Factor]
   760   C0018909:Haemagglutinin, NOS [Immunologic Factor]
   726   C0439851:Direct [Qualitative Concept]
   726   C1947931:Direct [Qualitative Concept]
Processing 00000000.tx.180: We have previously shown that, when inserted behind the second ATG, the hemagglutinin sequence does not modify the enzymes ability to bind insulin or its degrading activity, suggesting that the tagged endopeptidase was functional (36). 

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that,"

Phrase: "when"

Phrase: "inserted behind the second ATG,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0205436:Second [Quantitative Concept]
   760   C0441587:Inserted [Health Care Activity]
   760   C0457385:Second [Temporal Concept]
   760   C0565930:/second [Quantitative Concept]
   760   C1561503:second [Idea or Concept]
   760   C1705190:Second [Qualitative Concept]
   726 E C1743766:Insert [Medical Device]
   726 E C1883719:Insert [Functional Concept]

Phrase: "the hemagglutinin sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the enzymes ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085732:Ability [Organism Attribute]
   755 E C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "its degrading activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the tagged endopeptidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "was"

Phrase: "functional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205245:Functional [Functional Concept]
  1000   C0542341:Functional [Functional Concept]
  1000   C2700217:Functional [Conceptual Entity]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.181: The HA-tagged AL.pts appeared to have the same subcellular localization as the corresponding untagged protein. 

Phrase: "The HA-tagged AL.pts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1419129:PTS [Gene or Genome]
   812   C2698747:PTS [Intellectual Product]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "the same subcellular localization as the corresponding untagged protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0597704:protein localisation [Cell Function]
   762   C1159772:Protein Localization [Cell Function]
   742   C0475264:Localisation [Functional Concept]
   742   C1744691:localisation [Biologic Function]
Processing 00000000.tx.182: Figure 6D, which shows immunofluorescent labeling of the HA-tagged AL.pts, illustrates the second labeling pattern obtained for AL.pts and LV.pts. 

Phrase: "Figure 6D,"

Phrase: "which"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "immunofluorescent labeling of the HA-tagged AL.pts,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1167624:Labeling [Mental Process]
   744   C1947902:Labeling [Manufactured Object]
   744   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "illustrates"

Phrase: "the second labeling pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Pattern [Spatial Concept]

Phrase: "obtained for AL.pts"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1301820:Obtained [Functional Concept]
   770   C1419129:PTS [Gene or Genome]
   770   C2698747:PTS [Intellectual Product]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "LV.pts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]
Processing 00000000.tx.183: In contrast to the punctate catalase staining (Fig. 6E), both cytoplasm and nucleus appeared strongly labeled in this group of cells. 

Phrase: "In contrast to the punctate catalase staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "(Fig. 6E"

Phrase: ")"

Phrase: ","

Phrase: "both cytoplasm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "and"

Phrase: "nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "strongly"

Phrase: "labeled in this group of cells."
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   767   C2983610:Group Label [Intellectual Product]
   753   C0007634:Cells [Cell]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   753   C1708632:Labeled [Qualitative Concept]
   753   C3282337:Cells [Cell]
   719 E C0181496:Label [Manufactured Object]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
   719 E C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.184: The absence of colocalization with catalase was verified by confocal microscopy analysis. 

Phrase: "The absence of colocalization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "with catalase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "was"

Phrase: "verified by confocal microscopy analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0242842:Microscopy, Confocal [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1711411:Verified [Functional Concept]
Processing 00000000.tx.185: The labeling of cells expressing DEL.pts was essentially nuclear (data not shown). 

Phrase: "The labeling of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1167624:Labeling [Mental Process]
   770   C1947902:Labeling [Manufactured Object]
   770   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "expressing"

Phrase: "DEL.pts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]

Phrase: "was"

Phrase: "essentially nuclear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0521447:Nuclear [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.186: In cells expressing moderate levels of wtIDE, the enzyme was localized mostly to the peroxisomes as shown by the double labeling of wtIDE and the peroxisomal marker PMP70 on the same cells (Figs. 6, G and H). 

Phrase: "In cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "moderate levels of wtIDE,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "mostly to the peroxisomes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0750554:mostly [Idea or Concept]
   770   C0752063:Peroxisomes [Cell Component]
   737 E C2984308:Peroxisome [Functional Concept]

Phrase: "as"

Phrase: "shown by the double labeling of wtIDE"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   764   C1883559:Wild Type [Organism Attribute]
   742   C0205173:Double [Functional Concept]
   742   C0332307:Type [Qualitative Concept]
   742   C0445392:Wild [Intellectual Product]
   742   C1167624:Labeling [Mental Process]
   742   C1547052:*Type [Quantitative Concept]
   742   C1705764:Double [Activity]
   742   C1705765:Double [Qualitative Concept]
   742   C1947902:Labeling [Manufactured Object]
   742   C2827499:Labeling [Governmental or Regulatory Activity]
   708 E C0181496:Label [Manufactured Object]
   708   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "the peroxisomal marker PMP70 on the same cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1412090:PMP70 [Gene or Genome]

Phrase: "(Figs. 6,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.187: The same results were obtained using an antibody to catalase (not shown). 

Phrase: "The same results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an antibody to catalase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.188: In addition, a faint immunofluorescence for IDE could also be seen in the cytoplasm (Fig. 6G). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "a faint immunofluorescence for"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0016318:Immunofluorescence [Laboratory Procedure]
   770   C0079603:Immunofluorescence [Laboratory Procedure]
   715 E C0282648:Direct immunofluorescence [Laboratory Procedure]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "could"

Phrase: "also"

Phrase: "be"

Phrase: "seen in the cytoplasm"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0010834:Cytoplasm [Cell Component]
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "(Fig. 6G"

Phrase: ")."
Processing 00000000.tx.189: However, in cells overexpressing wtIDE, in addition to peroxisomes and the cytoplasm, the enzyme could be observed sometimes in the nucleus as noted above for the peroxisomal targeting mutants (data not shown). 

Phrase: "However,"

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "wtIDE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "in addition to peroxisomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]

Phrase: "and"

Phrase: "the cytoplasm,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "sometimes in the nucleus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0007610:Nucleus [Cell Component]
   770   C1998882:Sometimes [Temporal Concept]

Phrase: "as noted above"

Phrase: "for the peroxisomal targeting mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.190: Taken together, these data show that both point mutations of the human IDEs peroxisomal targeting signal, as well as its deletion, abolished the import of the protein into peroxisomes. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "both point mutations of the human IDEs peroxisomal targeting signal,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   739   C0026882:Mutations [Genetic Function]
   739   C1552961:Point [Quantitative Concept]
   739   C2347617:point [Quantitative Concept]
   706 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "as well as"

Phrase: "its deletion,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "abolished"

Phrase: "the import of the protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1326471:Protein Import [Cell Function]
   760   C0699788:Import [Occupational Activity]

Phrase: "into peroxisomes."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]
Processing 00000000.tx.191: Finally, in contrast to transiently transfected COS cells, only minimal nuclear staining was previously observed in Ltk- cells stably expressing wtIDE under an inducible promoter (31). 

Phrase: "Finally,"

Phrase: "in contrast to transiently transfected COS cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0376702:COS Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "only minimal nuclear staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0487602:Staining [Laboratory Procedure]
   812   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "previously"

Phrase: "observed in Ltk- cells stably"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C1441672:Observed [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "wtIDE under an inducible promoter"

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.192: To check if the strong nuclear labeling sometimes obtained in COS cells was cell type specific, we also transiently expressed wtIDE, HA epitope-tagged wtIDE, and AL.pts into Ltk- cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "check"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1283174:Check [Activity]

Phrase: "if"

Phrase: "the strong nuclear labeling sometimes"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   812   C0442821:Strong [Qualitative Concept]
   812   C0521447:Nuclear [Spatial Concept]
   812   C1167624:Labeling [Mental Process]
   812   C1947902:Labeling [Manufactured Object]
   812   C1998882:Sometimes [Temporal Concept]
   812   C2827499:Labeling [Governmental or Regulatory Activity]
   779 E C0181496:Label [Manufactured Object]
   741 E C0237897:Strength [Quantitative Concept]
   741 E C0808080:Strength [Idea or Concept]
   741 E C1705922:Strength [Qualitative Concept]

Phrase: "obtained in COS cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C0376702:COS Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0454802:Cos [Geographic Area]
   770   C1301820:Obtained [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1706701:Obtain [Activity]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "cell type specific,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C0007634:Cell Type [Cell]
           Cell
   901   C0449475:cell type [Intellectual Product]
   827   C0205369:Specific [Qualitative Concept]
   827   C0332307:Type [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1547052:*Type [Quantitative Concept]
   827   C1552740:specific [Intellectual Product]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "we also transiently"

Phrase: "expressed"

Phrase: "wtIDE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "HA epitope-tagged wtIDE,"

Phrase: "and"

Phrase: "AL.pts into Ltk- cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1419129:PTS [Gene or Genome]
   760   C2698747:PTS [Intellectual Product]
Processing 00000000.tx.193: The protein was detected using the 31H7 anti-IDE monoclonal antibody or the anti-HA antibody, and the same labeling pattern as in COS cells was obtained with all three constructs (not shown). 

Phrase: "The protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 31H7"

Phrase: "anti-"

Phrase: "IDE monoclonal antibody"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   876   C0021644:Insulin antibody [Immunologic Factor]
   861   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0746619:monoclonal [Finding]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C0014445:enzymes [Functional Concept]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "the anti-HA antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "the same labeling pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Pattern [Spatial Concept]

Phrase: "as in COS cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0376702:COS Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0454802:Cos [Geographic Area]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "obtained with all three constructs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0205449:Three [Quantitative Concept]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]
   726   C2827421:Construct [Classification]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.194: Although a physiological role for the nuclear IDE cannot be excluded at this point, these data suggest that overexpression of IDE in transiently transfected cells may also lead to its nuclear accumulation possibly by nonspecific translocation through the nuclear pores. 

Phrase: "Although"

Phrase: "a physiological role for the nuclear"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "cannot"

Phrase: "be"

Phrase: "excluded at this point,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C1552961:Point [Quantitative Concept]
   770   C1554077:Excluded [Idea or Concept]
   770   C2347617:point [Quantitative Concept]
   770   C2828389:Excluded [Activity]
   737 E C0332196:Exclude [Functional Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that overexpression of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514559:Overexpression [Genetic Function]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in transiently transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "also"

Phrase: "lead to its nuclear accumulation possibly"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0544910:Nuclear accumulation [Cell or Molecular Dysfunction]
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0521447:Nuclear [Spatial Concept]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C2362652:Possibly [Qualitative Concept]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "by nonspecific translocation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040715:Translocation [Cell or Molecular Dysfunction]
   861   C2987521:Translocation [Activity]

Phrase: "through the nuclear pores."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028587:Pores, Nuclear [Cell Component]
   861   C0521447:Nuclear [Spatial Concept]
   827   C1325742:Pore [Cell Component]
Processing 00000000.tx.195: This observation has been made previously in mammalian cells overexpressing peroxisomal proteins, including firefly luciferase (41), and in yeast (42, 43).  

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "has"

Phrase: "been"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "previously in mammalian cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   816   C1512977:Mammalian Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0024660:Mammalian [Mammal]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "peroxisomal proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "firefly luciferase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0311727:Firefly luciferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   861   C0162328:Firefly [Eukaryote]

Phrase: "(41"

Phrase: ")"

Phrase: ","

Phrase: "and in yeast"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0036025:yeast [Fungus]
   790   C0043392:Yeast [Food]
   790   C0043393:Yeast [Fungus]
   790   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   790   C1515981:And [Idea or Concept]

Phrase: "(42,"

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.196: Discussion Top Abstract Introduction Materials and Methods Results Discussion References  IDE was recently localized primarily to peroxisomes by immunofluorescence and immunoelectron microscopy using a cell line stably expressing IDE on an inducible vector (31). 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1514811:Reference [Idea or Concept]
   779   C1706462:Reference [Conceptual Entity]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "primarily to peroxisomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0752063:Peroxisomes [Cell Component]
   756 E C2984308:Peroxisome [Functional Concept]
   706 E C3546463:peroxisomal [Cell Component]

Phrase: "by immunofluorescence"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0016318:Immunofluorescence [Laboratory Procedure]
  1000   C0079603:Immunofluorescence [Laboratory Procedure]
   944 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   928 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "immunoelectron microscopy"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0079835:Microscopy, Immuno-Electron [Diagnostic Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a cell line stably"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007600:Cell Line [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "on an inducible vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.197: Induction of IDE expression increased insulin degradation by these cells. 

Phrase: "Induction of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0205263:Induction [Functional Concept]
   833   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "IDE expression"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "insulin degradation by these cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C3547574:insulin degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]
Processing 00000000.tx.198: In the present study, two mutations of human IDEs peroxisomal targeting signal abolished its import into peroxisomes but did not affect the ability of IDE to degrade insulin, either in vitro or in intact cells. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "two mutations of human IDEs peroxisomal targeting signal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0026882:Mutations [Genetic Function]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "abolished"

Phrase: "its import into peroxisomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0699788:Import [Occupational Activity]

Phrase: "but"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the ability of"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0085732:Ability [Organism Attribute]
   718 E C1299581:Able [Finding]

Phrase: "IDE to"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "degrade"

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "either in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]

Phrase: "or in intact cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   816   C0682538:intact cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0205266:Intact [Qualitative Concept]
   770   C1554187:Intact [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.199: This finding shows that IDE can degrade insulin without being localized to peroxisomes. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "can"

Phrase: "degrade"

Phrase: "insulin without"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   833   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   833   C1579433:Insulin [Pharmacologic Substance]
   777 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   750 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "being"

Phrase: "localized to peroxisomes."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0392752:Localized [Spatial Concept]
   790   C0752063:Peroxisomes [Cell Component]
   756 E C2984308:Peroxisome [Functional Concept]
   706 E C3546463:peroxisomal [Cell Component]
Processing 00000000.tx.200: The absence of a full-sized IDE and the slight presence of a lower molecular weight protein in extracts from cells transfected with the deletion mutant (DEL.pts) suggest that this mutant is rapidly degraded in the cytosol. 

Phrase: "The absence of a full-sized"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the slight presence of a lower molecular weight protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "from cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with the deletion mutant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C1442161:Deletion [Cell or Molecular Dysfunction]
   760   C1511760:Deletion [Genetic Function]
   760   C1880274:Deletion [Activity]

Phrase: "(DEL.pts)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "degraded in the cytosol."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1383501:Cytosol [Cell Component]
   770   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.201: It is surprising that the deletion of just three amino acids causes such a dramatic change in protein stability, whereas the two singly mutated IDEs (AL.pts and LV.pts) are stable. 

Phrase: "It"

Phrase: "is"

Phrase: "surprising"

Phrase: "that"

Phrase: "the deletion of just three amino acids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1442161:Deletion [Cell or Molecular Dysfunction]
   748   C1511760:Deletion [Genetic Function]
   748   C1880274:Deletion [Activity]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "such a dramatic change in protein stability,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]

Phrase: "whereas"

Phrase: "the two singly mutated IDEs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0328104:Ide [Fish]
   812   C1415875:IDE [Gene or Genome]
   812   C2826366:IDE [Idea or Concept]

Phrase: "(AL.pts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]

Phrase: "and"

Phrase: "LV.pts)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419129:PTS [Gene or Genome]
   861   C2698747:PTS [Intellectual Product]

Phrase: "are"

Phrase: "stable."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205360:Stable [Qualitative Concept]
  1000   C1547311:Stable [Intellectual Product]
Processing 00000000.tx.202: We cannot distinguish at this point whether this effect is cell-type specific, or more general. 

Phrase: "We"

Phrase: "cannot"

Phrase: "distinguish at this point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552961:Point [Quantitative Concept]
   770   C2347617:point [Quantitative Concept]

Phrase: "whether"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "cell-type specific,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C0007634:Cell Type [Cell]
           Cell
   901   C0449475:cell type [Intellectual Product]
   827   C0205369:Specific [Qualitative Concept]
   827   C0332307:Type [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1547052:*Type [Quantitative Concept]
   827   C1552740:specific [Intellectual Product]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "more general."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205246:General [Spatial Concept]
   861   C1553889:General [Idea or Concept]
Processing 00000000.tx.203: However, one possible explanation is that alanine or leucine mutants maintain association with molecules that protect them from degradation, although they are still incapable of peroxisomal translocation. 

Phrase: "However,"

Phrase: "one possible explanation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0681841:Explanation [Intellectual Product]

Phrase: "is"

Phrase: "that alanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "leucine mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "association with molecules"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004083:Association [Mental Process]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "that"

Phrase: "protect"

Phrase: "them from degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "although"

Phrase: "they"

Phrase: "are"

Phrase: "still incapable of peroxisomal translocation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1550518:incapable [Idea or Concept]
Processing 00000000.tx.204: There is evidence that cytosolic SKL binding factors such as the 70-kDa heat shock proteins are involved in peroxisomal import (27, 44). 

Phrase: "There"

Phrase: "is"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that cytosolic SKL binding factors such as the 70-kDa heat shock proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   702   C1521761:Factor [Functional Concept]
   702   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "involved in peroxisomal import"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0699788:Import [Occupational Activity]
   770   C1314939:Involved [Functional Concept]
   770   C3546463:peroxisomal [Cell Component]

Phrase: "(27,"

Phrase: "44"

Phrase: ")."
Processing 00000000.tx.205: Recently, a cytosolic 70-kDa protein has been found to be associated with the cytosolic pool of IDE in hepatoma HepG2 cells, and has been proposed to maintain the dual cytosolic and peroxisomal pools of IDE in a stable equilibrium (45). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "a cytosolic 70-kDa protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with the cytosolic pool of"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0337051:Pool [Geographic Area]
   753   C1383501:Cytosolic [Cell Component]
   753   C1509144:pool [Clinical Attribute]
   753   C2349200:Pool [Functional Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in hepatoma HepG2 cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C2717940:HepG2 Cells [Cell]
   896   C0677626:hepatoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "has"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "the dual cytosolic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1383501:Cytosolic [Cell Component]

Phrase: "and"

Phrase: "peroxisomal pools of"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0337051:pools [Geographic Area]
   756 E C1509144:pool [Clinical Attribute]
   756 E C2349200:Pool [Functional Concept]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in a stable equilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014653:Equilibrium [Organism Function]
   861   C1547026:Equilibrium [Quantitative Concept]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.206: Yet another possibility is that deletion of the COOH-terminal tripeptide of IDE somehow alters protein folding or conformation, resulting in reduced stability. 

Phrase: "Yet"

Phrase: "another possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that deletion of the COOH-terminal tripeptide of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1442161:Deletion [Cell or Molecular Dysfunction]
   744   C1511760:Deletion [Genetic Function]
   744   C1880274:Deletion [Activity]

Phrase: "IDE somehow"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "protein folding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162847:protein folding [Molecular Function]
   861   C0185026:Folding [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "conformation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026377:Conformation [Spatial Concept]

Phrase: "resulting in reduced stability."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0332294:Resulting in [Functional Concept]
   770   C0205360:Stability [Qualitative Concept]
   770   C0392756:Reduced [Qualitative Concept]
   770   C0678226:resulting [Functional Concept]
   770   C2347098:Stability [Qualitative Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]
Processing 00000000.tx.207: Interestingly, whereas the singly mutated proteins were found in both the cytoplasm and nucleus, the deletion mutant was almost exclusively nuclear (data not shown). 

Phrase: "Interestingly,"

Phrase: "whereas"

Phrase: "the singly mutated proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0298973:mutated protein [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "found in both"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "the cytoplasm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "and"

Phrase: "nucleus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "the deletion mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "almost exclusively nuclear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0521447:Nuclear [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.208: This observation reinforces the idea that the deletion mutant was not stable in the cytosol, and was rapidly degraded in this cell compartment. 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "reinforces"

Phrase: "the idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that"

Phrase: "the deletion mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "not stable in the cytosol,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205360:Stable [Qualitative Concept]
   760   C1547311:Stable [Intellectual Product]

Phrase: "and"

Phrase: "was"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "degraded in this cell compartment."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C1948049:Cell (compartment) [Spatial Concept]
           Cell
   806   C2349967:Cell compartment [Anatomical Structure]
   760   C0007634:Cell [Cell]
   760   C1185625:Compartment [Body Space or Junction]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1881707:DEGRADED [Phenomenon or Process]
   760   C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.209: Although wild-type IDE is primarily detected in peroxisomes, the protease is also present and may function in the cytosol. 

Phrase: "Although"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "primarily"

Phrase: "detected in peroxisomes,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0442726:Detected [Finding]
   790   C0752063:Peroxisomes [Cell Component]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   756 E C2984308:Peroxisome [Functional Concept]
   706 E C3546463:peroxisomal [Cell Component]

Phrase: "the protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Protease [Enzyme]

Phrase: "is"

Phrase: "also"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "may"

Phrase: "function in the cytosol."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1383501:Cytosol [Cell Component]
   770   C1705273:Function [Intellectual Product]
Processing 00000000.tx.210: Significant amounts were detected in the cytosol of Ltk- cells stably expressing inducible IDE (31), in CHO cells overexpressing IDE (32), and both in transiently transfected COS and Ltk- cells in the present study. 

Phrase: "Significant amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "detected in the cytosol of Ltk- cells stably"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   744   C0007634:Cells [Cell]
   744   C0442726:Detected [Finding]
   744   C1383501:Cytosol [Cell Component]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "inducible"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Inducible [Functional Concept]
  1000   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "in CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(32"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "both in transiently transfected COS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0238767:Both [Spatial Concept]
   760   C0454802:Cos [Geographic Area]
   760   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "Ltk- cells in the present study."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.211: Other peroxisomal proteins, including catalase, have been reported to be present also in the cytosol. 

Phrase: "Other peroxisomal proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "catalase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "also in the cytosol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1383501:Cytosol [Cell Component]
Processing 00000000.tx.212: Recent evidence that guinea pig liver peroxisomal and cytoplasmic catalases are two related but distinct proteins that differ in size and amino acid composition (46) suggests that catalase may function in both subcellular compartments. 

Phrase: "Recent evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that guinea pig liver"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]
   734   C0085979:Guinea pig, NOS [Mammal]
   734   C0999699:Guinea-pig [Mammal]

Phrase: "peroxisomal"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C3546463:peroxisomal [Cell Component]
   928 E C0752063:Peroxisomes [Cell Component]
   928 E C2984308:Peroxisome [Functional Concept]

Phrase: "and"

Phrase: "cytoplasmic catalases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007367:catalases [Amino Acid, Peptide, or Protein,Enzyme]
   827 E C1413138:CATALASE [Gene or Genome]

Phrase: "are"

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "but"

Phrase: "distinct proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "differ in size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0456389:size [Spatial Concept]

Phrase: "and"

Phrase: "amino acid composition"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   827   C0486616:Composition [Clinical Attribute]
   827   C1555710:composition [Idea or Concept]

Phrase: "(46"

Phrase: ")"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that catalase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "may"

Phrase: "function in both subcellular compartments."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1185625:Compartments [Body Space or Junction]
   760   C1382196:Compartments [Natural Phenomenon or Process]
   760   C1705273:Function [Intellectual Product]
   726 E C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.213: Several arguments support the hypothesis that IDE also functions in the cytosol. 

Phrase: "Several arguments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0680226:arguments [Social Behavior]
   827 E C1704769:Argument [Conceptual Entity]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that"

Phrase: "IDE also"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "functions in the cytosol."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1383501:Cytosol [Cell Component]
   770   C1705273:Function [Intellectual Product]
Processing 00000000.tx.214: First, the relative proportion of the protein in peroxisomes vs. the cytosol seems to be cell-type specific. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the relative proportion of the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709707:Proportion [Quantitative Concept]

Phrase: "in peroxisomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]

Phrase: "vs."

Phrase: "the cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "cell-type specific."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C0007634:Cell Type [Cell]
           Cell
   901   C0449475:cell type [Intellectual Product]
   827   C0205369:Specific [Qualitative Concept]
   827   C0332307:Type [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1547052:*Type [Quantitative Concept]
   827   C1552740:specific [Intellectual Product]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.215: In HepG2 cells, IDE was found to be mainly cytosolic, and the cytoplasmic pool appeared unchanged in cells undergoing peroxisomal proliferation (45). 

Phrase: "In HepG2 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "mainly cytosolic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1383501:Cytosolic [Cell Component]

Phrase: "and"

Phrase: "the cytoplasmic pool"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0337051:Pool [Geographic Area]
   861   C1509144:pool [Clinical Attribute]
   861   C2349200:Pool [Functional Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "unchanged in cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442739:Unchanged [Finding]
   790   C2346711:Unchanged [Qualitative Concept]

Phrase: "undergoing"

Phrase: "peroxisomal proliferation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C1519020:Peroxisome Proliferation [Cell Function]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.216: Secondly, IDE is fairly abundant in red blood cells (20) that lack peroxisomes. 

Phrase: "Secondly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205436:Secondly [Quantitative Concept]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "fairly abundant in red blood cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2346714:Abundant [Qualitative Concept]

Phrase: "(20"

Phrase: ")"

Phrase: "that lack peroxisomes."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0752063:Peroxisomes [Cell Component]
   827 E C2984308:Peroxisome [Functional Concept]
   777 E C3546463:peroxisomal [Cell Component]
Processing 00000000.tx.217: In the present study, the observation that the extent of insulin degradation appears to be unaffected by IDE peroxisomal localization is consistent with IDE degrading the hormone in the cytoplasm. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that"

Phrase: "the extent of insulin degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439792:Extent [Spatial Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "unaffected by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C2986417:Unaffected [Conceptual Entity]

Phrase: "IDE peroxisomal localization"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   861   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0475264:Localisation [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1744691:localisation [Biologic Function]
   799   C3546463:peroxisomal [Cell Component]
   791   C2262921:peroxisome localisation [Physiologic Function]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   727 E C0752063:Peroxisomes [Cell Component]
   727 E C2984308:Peroxisome [Functional Concept]
   716 E C0014445:enzymes [Functional Concept]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "consistent with"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332290:Consistent with [Idea or Concept]
           Consistent
   761 E C0332529:Consistencies [Qualitative Concept]
   761 E C1547017:Consistency [Quantitative Concept]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "degrading"

Phrase: "the hormone in the cytoplasm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019932:Hormone [Hormone]
Processing 00000000.tx.218: Indeed, the alanine and leucine mutants were able to degrade cellular insulin as well as the wild-type endopeptidase, which we have previously shown to act intracellularly (13). 

Phrase: "Indeed,"

Phrase: "the alanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "leucine mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "degrade"

Phrase: "cellular insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "as well as"

Phrase: "the wild-type endopeptidase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "which"

Phrase: "we"

Phrase: "have"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "intracellularly"

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.219: Because insulin degradation does not require IDE to be in peroxisomes, it is likely that IDE-mediated insulin degradation does not occur in these organelles. 

Phrase: "Because"

Phrase: "insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "IDE to"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "be in peroxisomes,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0752063:Peroxisomes [Cell Component]
   790   C2987476:Be [Conceptual Entity]
   756 E C2984308:Peroxisome [Functional Concept]
   706 E C3546463:peroxisomal [Cell Component]

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "IDE-mediated insulin degradation"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   877   C3547574:insulin degradation [Molecular Function]
   845   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   845   C0678637:enzyme degradation [Laboratory Procedure]
   845   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   795   C0014442:Enzyme [Enzyme,Organic Chemical]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0086597:mediated [Social Behavior]
   795   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   795   C0243125:degradation [Functional Concept]
   795   C0699900:Degradation [Organism Function]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C0014445:enzymes [Functional Concept]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "occur in these organelles."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0029219:Organelles [Cell Component]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.220: If this is the case, then one might expect the level of insulin degradation to be higher in cells expressing the singly mutated IDEs than in those expressing the wild-type enzyme, where some of the IDE is sequestered in peroxisomes. 

Phrase: "If"

Phrase: "this"

Phrase: "is"

Phrase: "the case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "then one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "might"

Phrase: "expect"

Phrase: "the level of insulin degradation to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0202098:Insulin level [Laboratory Procedure]
   783   C0428405:insulin level [Laboratory or Test Result]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "be"

Phrase: "higher in cells"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "expressing"

Phrase: "the singly mutated IDEs than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0328104:Ide [Fish]
   760   C1415875:IDE [Gene or Genome]
   760   C2826366:IDE [Idea or Concept]

Phrase: "in those expressing"

Phrase: "the wild-type enzyme,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "where"

Phrase: "some of the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205392:Some [Quantitative Concept]
   790   C3540770:Some [Intellectual Product]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "sequestered in peroxisomes."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0333312:Sequestered [Functional Concept]
   790   C0752063:Peroxisomes [Cell Component]
   756 E C2984308:Peroxisome [Functional Concept]
   706 E C3546463:peroxisomal [Cell Component]
Processing 00000000.tx.221: The fact that no significant difference was observed may suggest that the further increase in the cytosolic enzyme population was no longer rate-limiting for insulin degradation. 

Phrase: "The fact"

Phrase: "that"

Phrase: "no significant difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "may"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the further increase in the cytosolic enzyme population"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "no longer rate-limiting for insulin degradation."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0439801:limiting [Functional Concept]
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]
   714 E C1549649:Limit [Idea or Concept]
   714 E C2349209:Limit [Conceptual Entity]
Processing 00000000.tx.222: Alternatively, the incremental increase in cytosolic IDE may have been too small to detect because of an already high proportion of cytosolic enzyme, underestimated in immunofluorescence experiments as a result of the diffuse nature of cytosolic staining. 

Phrase: "Alternatively,"

Phrase: "the incremental increase in cytosolic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "have"

Phrase: "been"

Phrase: "too small to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0700321:Small [Quantitative Concept]

Phrase: "detect because of an already high proportion of cytosolic enzyme,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0014442:Enzyme [Enzyme,Organic Chemical]
   739   C0205250:High [Qualitative Concept]
   739   C0442726:detect [Finding]
   739   C1299351:High [Qualitative Concept]
   739   C1383501:Cytosolic [Cell Component]
   739   C1709707:Proportion [Quantitative Concept]
   739   C2700149:HIGH [Intellectual Product]

Phrase: "underestimated in immunofluorescence experiments"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0016318:Immunofluorescence [Laboratory Procedure]
   770   C0079603:Immunofluorescence [Laboratory Procedure]
   770   C0681814:Experiments [Research Activity]
   737 E C1706386:Experiment [Conceptual Entity]
   715 E C0282648:Direct immunofluorescence [Laboratory Procedure]

Phrase: "as a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of the diffuse nature"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "of cytosolic staining."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]
Processing 00000000.tx.223: Finally, it may also result from retrafficking of the peroxisomal enzyme population to a location that is not involved in insulin degradation, such as the nucleus. 

Phrase: "Finally,"

Phrase: "it"

Phrase: "may"

Phrase: "also"

Phrase: "result from retrafficking of the peroxisomal enzyme population"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0032659:Population [Quantitative Concept]
   744   C1257890:Population [Population Group]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]
   744   C3546463:peroxisomal [Cell Component]

Phrase: "to a location"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450429:Location [Spatial Concept]
  1000   C1515974:Location [Body Location or Region]

Phrase: "that"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involved in insulin degradation,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C3547574:insulin degradation [Molecular Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]
   770   C1314939:Involved [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "such as the nucleus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]
Processing 00000000.tx.224: Although insulin is internalized via receptor-mediated endocytosis, and can be degraded in endosomes or lysosomes (reviewed in 3 , the hormone has been also detected in the cytoplasm and the nucleus (47, 48, 49). 

Phrase: "Although"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "internalized via receptor-mediated endocytosis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0597361:Receptor Mediated Endocytosis [Cell Function]
   760   C0014139:Endocytosis [Cell Function]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C2984285:Endocytosis [Functional Concept]

Phrase: "and"

Phrase: "can"

Phrase: "be"

Phrase: "degraded in endosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034850:Endosomes [Cell Component]
   790   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "or"

Phrase: "lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "("

Phrase: "reviewed in 3 ,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "the hormone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019932:Hormone [Hormone]
   928 E C0458083:Hormonal [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "also"

Phrase: "detected in the cytoplasm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010834:Cytoplasm [Cell Component]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "(47,"

Phrase: "48,"

Phrase: "49"

Phrase: ")."
Processing 00000000.tx.225: Several studies suggest that a second and sometimes a third pathway may exist for insulin internalization, involving noncoated pits and fluid-phase endocytosis (50, 51). 

Phrase: "Several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "and"

Phrase: "sometimes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998882:Sometimes [Temporal Concept]

Phrase: "a third pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "may"

Phrase: "exist for insulin internalization,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0871786:internalization [Mental Process]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C2987476:Exist [Conceptual Entity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "noncoated pits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0175697:PIT [Congenital Abnormality,Disease or Syndrome]
   827   C2697656:PIT [Gene or Genome]

Phrase: "and"

Phrase: "fluid-phase endocytosis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0031945:fluid-phase endocytosis [Cell Function]
   827   C0005889:FLUID [Body Substance]
   827   C0014139:Endocytosis [Cell Function]
   827   C0205390:Phase [Temporal Concept]
   827   C0302908:fluid [Substance]
   827   C0444611:Fluid [Qualitative Concept]
   827   C1704353:Fluid [Substance]
   827   C2984285:Endocytosis [Functional Concept]

Phrase: "(50,"

Phrase: "51"

Phrase: ")."
Processing 00000000.tx.226: More recently, the hypothesis has been proposed that undegraded insulin could exit early endosomes and be translocated to the nucleus via the cytoplasm (48, 49). 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "has"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that undegraded insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "could"

Phrase: "exit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337094:Exit [Spatial Concept]
  1000   C1550550:exit [Temporal Concept]

Phrase: "early endosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0887883:Early endosome [Cell Component]
   861   C0034850:Endosomes [Cell Component]

Phrase: "and"

Phrase: "be"

Phrase: "translocated to the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0007610:Nucleus [Cell Component]

Phrase: "via the cytoplasm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "(48,"

Phrase: "49"

Phrase: ")."
Processing 00000000.tx.227: Degradation of insulin in the cytoplasm is blocked in a number of cells by metalloprotease inhibitors of the type that inhibits IDE (8, 9, 10). 

Phrase: "Degradation of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C3547574:insulin degradation [Molecular Function]
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "in the cytoplasm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "is"

Phrase: "blocked in a number of cells"
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0007634:Cells [Cell]
   753   C0028778:Blocked [Pathologic Function]
   753   C0237753:*Number [Quantitative Concept]
   753   C0332206:Blocked [Functional Concept]
   753   C0449788:Number [Quantitative Concept]
   753   C2983591:BLOCKED [Research Activity]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1533157:Block [Substance]
   719 E C1704653:Cell [Medical Device]
   719 E C1706084:Block [Geographic Area]
   719 E C1948049:Cell [Spatial Concept]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "by metalloprotease inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1152589:metalloprotease inhibitor [Molecular Function]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "of the type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332307:Type [Qualitative Concept]
  1000   C1547052:*Type [Quantitative Concept]

Phrase: "that"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(8,"

Phrase: "9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.228: Furthermore, specific anti-IDE antibodies were shown to block insulin degradation in cell cultures, supporting a role for IDE in insulin degradation (11, 14). 

Phrase: "Furthermore,"

Phrase: "specific anti-"

Phrase: "IDE antibodies"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   875   C0021644:Insulin Antibodies [Immunologic Factor]
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "insulin degradation in cell cultures,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C0007585:Cell Cultures [Laboratory Procedure]
   804   C0010453:Cultures [Idea or Concept]
   771 E C0220814:culture [Functional Concept]
   771 E C0430400:Culture [Laboratory Procedure]
   771 E C2242979:Culture [Laboratory Procedure]
   708   C0030281:Insulin Cell [Cell]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "a role for"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "(11,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.229: Taken together, these data are consistent with a cytosolic pathway for insulin degradation by IDE. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "consistent with a cytosolic pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "for insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "by"

Phrase: "IDE."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.230: It is likely that IDE plays different roles in peroxisomes and in the cytosol. 

Phrase: "It"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "different roles in peroxisomes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "and in the cytosol."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1383501:Cytosol [Cell Component]
   770   C1515981:And [Idea or Concept]
Processing 00000000.tx.231: IDE is a member of a recently described family of metallopeptidases that share a HXXEH Zn2+ binding motif in their catalytic domain. 

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "a member of a recently described family of metallopeptidases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0086282:Family member [Family Group]
   762   C1611821:Family Member [Intellectual Product]
   742   C0680022:member [Population Group]
   742   C2698041:Member [Professional or Occupational Group]

Phrase: "that"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "a HXXEH Zn2+ binding motif in their catalytic domain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1514562:Motif [Amino Acid Sequence]
Processing 00000000.tx.232: Interestingly, several members of this family have been implicated in proteolytic maturation processes, such as presequence processing of nuclear encoded mitochondrial proteins (52, 53), or prohormone maturation (23). 

Phrase: "Interestingly,"

Phrase: "several members of this family"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C0086282:Family Members [Family Group]
   781 E C1611821:Family Member [Intellectual Product]
   760   C0680022:members [Population Group]
   726 E C2698041:Member [Professional or Occupational Group]

Phrase: "have"

Phrase: "been"

Phrase: "implicated in proteolytic maturation processes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0597304:Proteolytic [Molecular Function]
   760   C0678723:Maturation [Organism Function]
   760   C0870861:maturation [Phenomenon or Process]
   760   C1254042:Maturation [Physiologic Function]
   760   C1947941:proteolytic [Enzyme]
   726   C1184743:Process [Body Part, Organ, or Organ Component]
   726   C1522240:Process [Phenomenon or Process]

Phrase: "such as presequence processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "of nuclear encoded mitochondrial proteins"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   991   C1412946:nuclear encoded mitochondrial protein [Gene or Genome]
   902   C0028589:Nuclear Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   886 E C0949374:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0949610:Mitochondrial Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(52,"

Phrase: "53"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "prohormone maturation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0678723:Maturation [Organism Function]
   861   C0870861:maturation [Phenomenon or Process]
   861   C1254042:Maturation [Physiologic Function]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.233: IDE could thus perform a similar function in peroxisomes. 

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "could"

Phrase: "thus"

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "a similar function in peroxisomes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
Processing 00000000.tx.234: Although most peroxisomal proteins are synthesized in their mature state, some exceptions have been shown to require proteolytic maturation (27, 28). 

Phrase: "Although"

Phrase: "most peroxisomal proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "synthesized in their mature state,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205286:Mature [Temporal Concept]
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C1883254:Synthesized [Activity]
   760   C3148680:State [Geographic Area]

Phrase: "some exceptions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1554961:exception [Idea or Concept]
   966   C1705847:Exception [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "require"

Phrase: "proteolytic maturation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0678723:Maturation [Organism Function]
   861   C0870861:maturation [Phenomenon or Process]
   861   C1254042:Maturation [Physiologic Function]

Phrase: "(27,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.235: In these cases, the absence of processing in mutant cells defective in peroxisome biogenesis suggests that the proteolytic processing events are performed by one or more proteases present, but still unidentified, in peroxisomes (28). 

Phrase: "In these cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "the absence of processing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "in mutant cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "defective in peroxisome biogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332452:Defective [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the proteolytic processing events"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441471:Events [Event]
   827   C3541888:Events [Classification]
   734   C1514570:Proteolytic Processing [Molecular Function]

Phrase: "are"

Phrase: "performed by one"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C1550369:Performed By [Qualitative Concept]
   790   C0205447:One [Quantitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "or"

Phrase: "more proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: ","

Phrase: "but"

Phrase: "still unidentified,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205427:Unidentified [Qualitative Concept]

Phrase: "in peroxisomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.236: Interestingly, the potential multifunctional role of IDE may extend to other members of its family. 

Phrase: "Interestingly,"

Phrase: "the potential multifunctional role of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "extend to other members of its family."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   774   C0086282:Family Members [Family Group]
   757 E C1611821:Family Member [Intellectual Product]
   748   C0015576:Family [Family Group]
   748   C0231448:Extend [Functional Concept]
   748   C0439792:extend [Spatial Concept]
   748   C0680022:members [Population Group]
   748   C1704727:Family [Conceptual Entity]
   714 E C2698041:Member [Professional or Occupational Group]
Processing 00000000.tx.237: Indeed, two yeast homologs, Axl1p and Ste23, have recently been implicated in a-factor pheromone precursor processing (23). 

Phrase: "Indeed,"

Phrase: "two yeast homologs,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C1334043:Homolog [Gene or Genome]
   721 E C2697616:Homology [Qualitative Concept]

Phrase: "Axl1p"

Phrase: "and"

Phrase: "Ste23,"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "implicated in a-factor pheromone precursor processing"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0960756:factor A [Organic Chemical]
   774   C1159311:pheromone processing [Molecular Function]
   748   C0031516:Pheromone [Biologically Active Substance]
   748   C1521761:Factor [Functional Concept]
   748   C1709634:Precursor [Idea or Concept]
   748   C1709694:Processing [Activity]
   748   C2827422:Factor [Conceptual Entity]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.238: In addition, Axl1p appears to function as a morphogenetic determinant for axial bud selection. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "Axl1p"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "function as a morphogenetic determinant"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0026559:Morphogenesis, function [Organism Function]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1521761:Determinant [Functional Concept]
   760   C1705273:Function [Intellectual Product]

Phrase: "for axial bud selection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036576:selection [Genetic Function]
Processing 00000000.tx.239: Furthermore, amino acid substitutions in the HXXEH motif caused defects in propheromone processing but failed to perturb bud site selection, suggesting that participation of Axl1p in axial budding does not require proteolysis. 

Phrase: "Furthermore,"

Phrase: "amino acid substitutions in the HXXEH motif caused defects"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0525038:Substitutions, Amino Acid [Genetic Function,Molecular Biology Research Technique]
   708   C1555721:Substitution [Idea or Concept]
   708   C1706204:Substitution [Activity]

Phrase: "in propheromone processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "but"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "perturb"

Phrase: "bud site selection,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0036576:selection [Genetic Function]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2700462:Bud [Plant]
   827   C2825164:Site [Spatial Concept]
   827   C2945744:bud [Anatomical Structure]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that participation of Axl1p"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0679823:Participation [Functional Concept]

Phrase: "in axial budding"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1749575:axial budding [Cell Function]
   861   C1155616:budding [Cell Function]
   827 E C2700462:Bud [Plant]
   827 E C2945744:bud [Anatomical Structure]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "proteolysis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]
Processing 00000000.tx.240: Because most of the proteins of this family of metallopeptidases are especially large compared with common proteases, this observation raises the possibility of a division of the protein into distinct functional domains. 

Phrase: "Because"

Phrase: "most of the proteins of this family of metallopeptidases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   745   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0015576:Family [Family Group]
   742   C0025543:Metallopeptidases [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205393:Most [Quantitative Concept]
   742   C1704727:Family [Conceptual Entity]

Phrase: "are"

Phrase: "especially large"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0549177:Large [Quantitative Concept]

Phrase: "compared with common proteases,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0205214:Common [Quantitative Concept]
   770   C1522138:Common [Functional Concept]
   770   C1707455:Compared [Activity]
   770   C1947941:Proteases [Enzyme]
   770   C3245511:common [Intellectual Product]

Phrase: "this observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "raises"

Phrase: "the possibility of a division of the protein"

Phrase: "into distinct functional domains."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.241: Although IDE and mitochondrial processing peptidase are quite divergent in terms of amino acid sequence, size and quaternary structure, mitochondrial processing peptidase -subunit also contains the HXXEH consensus pentapeptide (52, 53). 

Phrase: "Although"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "mitochondrial processing peptidase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0128584:mitochondrial processing peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030940:Peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1947941:Peptidase [Enzyme]
   734   C1156082:mitochondrial processing [Cell Function]

Phrase: "are"

Phrase: "quite divergent in terms of amino acid sequence,"

Phrase: "size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456389:size [Spatial Concept]

Phrase: "and"

Phrase: "quaternary structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "mitochondrial processing peptidase -subunit also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1711351:Subunit [Quantitative Concept]
   717   C0128584:mitochondrial processing peptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the HXXEH consensus pentapeptide"

Phrase: "(52,"

Phrase: "53"

Phrase: ")."
Processing 00000000.tx.242: In addition to its involvement in presequence proteolytic maturation of nucleus-encoded mitochondrial proteins, this metallopeptidase has also been reported to be part of the respiratory chain bc1 complex in Neurospora crassa and plants, although the two functions appear clearly distinct in yeast and mammals. 

Phrase: "In addition to its involvement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involvement [Functional Concept]

Phrase: "in presequence proteolytic maturation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0678723:Maturation [Organism Function]
   827   C0870861:maturation [Phenomenon or Process]
   827   C1254042:Maturation [Physiologic Function]

Phrase: "of nucleus-encoded mitochondrial proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0949610:Mitochondrial Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "this metallopeptidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025543:Metallopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "part of the respiratory chain bc1 complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1292711:Part of [Spatial Concept]
   748   C0449719:Part [Spatial Concept]
   748   C1709471:Part [Quantitative Concept]

Phrase: "in Neurospora crassa"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027923:Neurospora crassa [Fungus]
   861   C0027922:Neurospora [Fungus]
   861   C3311958:Crassa [Eukaryote]

Phrase: "and"

Phrase: "plants,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0032098:Plants [Plant]
   900 E C0006038:Botany [Occupation or Discipline]
   884 E C1456557:Botanical [Organic Chemical,Pharmacologic Substance]

Phrase: "although"

Phrase: "the two functions"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "clearly distinct in yeast"

Phrase: "and"

Phrase: "mammals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024660:Mammals [Mammal]
Processing 00000000.tx.243: Because mutations that alter IDEs peroxisomal targeting signal do not alter IDEs ability to regulate cellular insulin degradation, it appears that this function does not require peroxisomal localization. 

Phrase: "Because"

Phrase: "mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "IDEs peroxisomal targeting signal"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C1521840:Targeting [Functional Concept]
   812   C1710082:Signal [Phenomenon or Process]
   812   C3546463:peroxisomal [Cell Component]
   779 E C2986546:TARGET [Diagnostic Procedure]
   741 E C0752063:Peroxisomes [Cell Component]
   741 E C2984308:Peroxisome [Functional Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "IDEs ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085732:Ability [Organism Attribute]
   755 E C1299581:Able [Finding]

Phrase: "regulate"

Phrase: "cellular insulin degradation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1523935:cellular degradation [Cell Function]
   901   C3547574:insulin degradation [Molecular Function]
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "it"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "that"

Phrase: "this function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "peroxisomal localization."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C2262921:peroxisome localisation [Physiologic Function]
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]
Processing 00000000.tx.244: This suggests that IDE may be a multifunctional protein and that other peroxisomal functions for IDE should continue to be sought. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "a multifunctional protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "that"

Phrase: "other peroxisomal functions for"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0542341:Functions [Functional Concept]
   737 E C0031843:function [Physiologic Function]
   737 E C0700205:FUNCTION [Classification]
   737 E C1705273:Function [Intellectual Product]

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "should"

Phrase: "continue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continue [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "sought."
Processing 00000000.tx.245: The diversity of biochemical reactions performed by peroxisomes leaves open a wide range of possible roles.  

Phrase: "The diversity of biochemical reactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880371:Diversity [Qualitative Concept]

Phrase: "performed by peroxisomes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C1550369:Performed By [Qualitative Concept]
   790   C0752063:Peroxisomes [Cell Component]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]
   756 E C2984308:Peroxisome [Functional Concept]
   706 E C3546463:peroxisomal [Cell Component]

Phrase: "leaves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242724:Leaves [Plant]

Phrase: "open"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175566:Open [Spatial Concept]

Phrase: "a wide range of possible roles."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1514721:Range [Quantitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]
Processing 00000000.tx.246: Footnotes  1 This work was supported by a gift from the Cornelius Crane Trust (to M.R.R.). 

Phrase: "Footnotes  1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2825232:Footnote [Intellectual Product]

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by a gift"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "from the Cornelius Crane Trust"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0237935:Trust [Individual Behavior]
   827   C3245466:trust [Idea or Concept]

Phrase: "("

Phrase: "to"

Phrase: "M."

Phrase: "R.R."

Phrase: ")."
Processing 00000000.tx.247: 2 Equal author contribution. 

Phrase: "2 Equal author contribution."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1880177:Contribution [Activity]
Processing 00000000.tx.248: 3 Recipient of fellowship from the Association pour la Recherche contre le Cancer. 

Phrase: "3 Recipient of fellowship"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709854:Recipient [Human]

Phrase: "from the Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "pour"

Phrase: "la Recherche contre le Cancer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0006826:Cancer [Neoplastic Process]
   804   C0998265:Cancer [Eukaryote]
   804   C1306459:Cancer [Finding]
Processing 00000000.tx.249: Received February 27, 1997.  

Phrase: "Received February 27,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "1997."
Processing 00000000.tx.250: References Top Abstract Introduction Materials and Methods Results Discussion References  Czech MP 1989 Signal transmission by the insulin-like growth factors. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Czech MP 1989 Signal transmission by the insulin-like growth factors."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0040722:transmission [Idea or Concept]
   738   C0242781:Transmission [Pathologic Function]
   738   C1521797:Transmission [Natural Phenomenon or Process]
Processing 00000000.tx.251: Cell 59:235238[Medline] Rosen OM 1987 After insulin binds. 

Phrase: "Cell 59"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "235238"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rosen OM 1987 After insulin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0028971:OM [Geographic Area]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C1705272:OM [Idea or Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "binds."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]
Processing 00000000.tx.252: Science 237:14521458[Medline] Duckworth WC 1988 Insulin degradation: mechanisms, products, and significance. 

Phrase: "Science 237"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "14521458"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Duckworth WC 1988 Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C3547574:insulin degradation [Molecular Function]
   804   C0243125:degradation [Functional Concept]
   804   C0699900:Degradation [Organism Function]

Phrase: ":"

Phrase: "mechanisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "products,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "significance."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.253: Endocr Rev 9:319345[Abstract] Levy JR, Olefsky JM 1986 Retroendocytosis of insulin in rat adipocytes. 

Phrase: "Endocr Rev 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "319345"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Levy JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Olefsky JM 1986 Retroendocytosis of insulin"

Phrase: "in rat adipocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206131:Adipocytes [Cell]
Processing 00000000.tx.254: Endocrinology 119:572579[Abstract] Gehm BD, Kuo W-L, Perlman RK, Rosner MR 1993 Mutations in a zinc-binding domain of human insulin-degrading enzyme eliminate catalytic activity but not insulin binding. 

Phrase: "Endocrinology 119"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "572579"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Gehm BD,"

Phrase: "Kuo W-L,"

Phrase: "Perlman RK,"

Phrase: "Rosner MR 1993 Mutations in a zinc-binding domain"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0026882:Mutations [Genetic Function]
   708 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "of human insulin-degrading enzyme"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   861   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "eliminate"

Phrase: "catalytic activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0243102:catalytic activity [Molecular Function]
  1000   C1264638:Catalytic activity [Functional Concept]
  1000   C1547012:*Catalytic Activity [Quantitative Concept]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "but"

Phrase: "not insulin binding."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C1623517:insulin binding [Molecular Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.255: J Biol Chem 268:79437948[Abstract/Free FullText] Hamel FG, Posner BI, Bergeron JJM, Frank BH, Duckworth WC 1988 Isolation of insulin degradation products from endosomes derived from intact rat liver. 

Phrase: "J Biol Chem 268"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "79437948"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Posner BI,"

Phrase: "Bergeron JJM,"

Phrase: "Frank BH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004684:BH [Geographic Area]
   861   C1412800:BH [Gene or Genome]
   861   C2986890:BH [Idea or Concept]

Phrase: "Duckworth WC 1988 Isolation of insulin degradation products"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0204727:Isolation [Therapeutic or Preventive Procedure]
   744   C0205409:Isolation [Functional Concept]
   744   C0220862:isolation [Laboratory Procedure]

Phrase: "from endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "derived from intact rat liver."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   806   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   760   C0023884:Liver [Body Part, Organ, or Organ Component]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0205266:Intact [Qualitative Concept]
   760   C0736268:LIVER [Body Part, Organ, or Organ Component]
   760   C1278929:Liver [Body Part, Organ, or Organ Component]
   760   C1441547:Derived [Qualitative Concept]
   760   C1554187:Intact [Idea or Concept]
   760   C2346688:LIVER [Food]
   760   C3245521:derived [Idea or Concept]
   704 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.256: J Biol Chem 263:67036708[Abstract/Free FullText] Duckworth WC, Hamel FG, Peavey DE, Liepnieks JJ, Ryan MP, Hermodson MA, Frank BH 1988 Degradation products of insulin generated by hepatocytes and insulin protease. 

Phrase: "J Biol Chem 263"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "67036708"

Phrase: "[Abstract/Free FullText"

Phrase: "] Duckworth WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Peavey DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Liepnieks JJ,"

Phrase: "Ryan MP,"

Phrase: "Hermodson MA,"

Phrase: "Frank BH 1988 Degradation products of insulin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0021641:insulin products [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1514468:Products [Entity]
   714 E C1704444:Product [Quantitative Concept]

Phrase: "generated by hepatocytes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0227525:Hepatocytes [Cell]
   790   C3146294:Generated [Activity]
   756 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "insulin protease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021669:Insulin Protease [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]
Processing 00000000.tx.257: J Biol Chem 263:18261833[Abstract/Free FullText] Kayalar C, Wong WT 1989 Metalloprotease inhibitors which block the differentiation of L6 myoblasts inhibit insulin degradation by the endogenous insulin-degrading enzyme. 

Phrase: "J Biol Chem 263"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "18261833"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kayalar C,"

Phrase: "Wong WT 1989 Metalloprotease inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   823   C1152589:metalloprotease inhibitor [Molecular Function]
   804   C0243077:inhibitors [Chemical Viewed Functionally]
   771 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "which"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the differentiation of L6 myoblasts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C1159966:myoblast differentiation [Cell Function]
   760   C0007589:Differentiation [Cell Function]
   760   C1511938:Differentiation [Clinical Attribute]
   760   C2945687:Differentiation [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulin degradation by the endogenous insulin-degrading enzyme."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C3547574:insulin degradation [Molecular Function]
   767   C0678637:enzyme degradation [Laboratory Procedure]
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]
Processing 00000000.tx.258: J Biol Chem 264:89288934[Abstract/Free FullText] Kayalar C, Wong WT, Hendrickson L 1990 Differentiation of BC3H1 and primary skeletal muscle cells and the activity of their endogenous insulin-degrading enzyme are inhibited by the same metalloendoprotease inhibitors. 

Phrase: "J Biol Chem 264"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "89288934"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kayalar C,"

Phrase: "Wong WT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2700323:WT [Fish]

Phrase: "Hendrickson L 1990 Differentiation of BC3H1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0007589:Differentiation [Cell Function]
   753   C1511938:Differentiation [Clinical Attribute]
   753   C2945687:Differentiation [Functional Concept]

Phrase: "and"

Phrase: "primary skeletal muscle cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   890   C1704336:Skeletal muscle cell [Cell]
   861   C0242692:Muscle, Skeletal [Tissue]
   861   C0596981:Muscle Cells [Cell]
   861   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0037253:skeletal [Body System]
   812   C0521324:Skeletal [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "the activity of their endogenous insulin-degrading enzyme"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0243102:enzyme activity [Molecular Function]
   767   C1145751:insulin activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "are"

Phrase: "inhibited by the same metalloendoprotease inhibitors."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   753   C0311403:Inhibited [Qualitative Concept]
   753   C0445247:Same [Qualitative Concept]
   719 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.259: J Cell Biochem 44:137151[Medline] Gehm BD, Rosner MR 1991 Regulation of insulin, epidermal growth factor and transforming growth factor alpha levels by growth factor degrading enzymes. 

Phrase: "J Cell Biochem 44"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "137151"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gehm BD,"

Phrase: "Rosner MR 1991 Regulation of insulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "epidermal growth factor"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1323367:epidermal growth factor [Molecular Function]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0014520:Epidermal [Tissue]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0221920:Epidermal [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   711 E C3496194:Epidermis [Cell]

Phrase: "and"

Phrase: "transforming growth factor alpha levels by growth factor degrading enzymes."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   757   C0014440:enzymes levels [Laboratory Procedure]
   757   C1287349:enzymes levels [Laboratory or Test Result]
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.260: Endocrinology 128:16031610[Abstract] Shii K, Roth RA 1986 Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease. 

Phrase: "Endocrinology 128"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "16031610"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Shii K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Roth RA 1986 Inhibition of insulin degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by hepatoma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C0677626:hepatoma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0023903:Hepatoma [Neoplastic Process]
   861   C2239176:Hepatoma [Neoplastic Process]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "after microinjection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025991:Microinjection [Therapeutic or Preventive Procedure]

Phrase: "of monoclonal antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0746619:monoclonal [Finding]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to a specific cytosolic protease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Protease [Enzyme]
Processing 00000000.tx.261: Proc Natl Acad Sci USA 83:41744151 Hari J, Shii K, Roth RA 1987 In vivo association of [125I]-insulin with a cytosolic insulin-degrading enzyme: detection by covalent cross-linking and immunoprecipitation with a monoclonal antibody. 

Phrase: "Proc Natl Acad Sci USA 83"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "41744151 Hari J,"

Phrase: "Shii K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Roth RA 1987 In vivo association of [125I"

Phrase: "]-insulin with a cytosolic insulin-degrading enzyme"

Phrase: ":"

Phrase: "detection by covalent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "immunoprecipitation with a monoclonal antibody."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.262: Endocrinology 120:829831[Abstract] Kuo W-L, Gehm BD, Rosner MR 1991 Regulation of insulin degradation: expression of an evolutionarily conserved insulin-degrading enzyme increases degradation by an intracellular pathway. 

Phrase: "Endocrinology 120"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "829831"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kuo W-L,"

Phrase: "Gehm BD,"

Phrase: "Rosner MR 1991 Regulation of insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1158158:regulation of degradation [Molecular Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: ":"

Phrase: "expression of an evolutionarily conserved insulin-degrading enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "degradation by an intracellular pathway."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1511758:Degradation Pathway [Conceptual Entity]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]
Processing 00000000.tx.263: Mol Endocrinol 5:14671476[Abstract] Semple JW, Lang Y, Speck ER, Delovitch TL 1992 Processing and presentation of insulin. 

Phrase: "Mol Endocrinol 5"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0027960:Mole [Neoplastic Process]
   827   C0324740:Mole [Mammal]
   827   C0439189:Mole [Quantitative Concept]
   827   C1456781:mole [Neoplastic Process]
   827   C1824986:mol [Gene or Genome]
   743 E C0026367:Molar [Body Part, Organ, or Organ Component]
   727 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "14671476"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Semple JW,"

Phrase: "Lang Y,"

Phrase: "Speck ER,"

Phrase: "Delovitch TL 1992 Processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "presentation of insulin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0449450:Presentation [Idea or Concept]
Processing 00000000.tx.264: III. 

Phrase: "III."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]
Processing 00000000.tx.265: Insulin degrading enzyme: a neutral metalloendoproteinase that is non-homologous to classical endoproteinases mediates the processing of insulin epitopes for helper T cells. 

Phrase: "Insulin degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "a neutral metalloendoproteinase"

Phrase: "that"

Phrase: "is"

Phrase: "non-homologous to classical endoproteinases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1334043:Homologous [Gene or Genome]
   760   C1518422:Non [Functional Concept]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the processing of insulin epitopes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1158354:insulin processing [Molecular Function]
   760   C1709694:Processing [Activity]

Phrase: "for helper T cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0018894:Helper T-Cells [Cell]
           Helper Cells
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.266: Int Immunol 4:11611167[Abstract] Roth RA, Mesirow ML, Yokono K, Baba S 1984 Degradation of insulin-like growth factors I and II by a human insulin-degrading enzyme. 

Phrase: "Int Immunol 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0063789:INT [Organic Chemical]
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
   827   C3272375:INT [Intellectual Product]

Phrase: ":"

Phrase: "11611167"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Roth RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Mesirow ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Yokono K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Baba S 1984 Degradation of insulin-like growth factors I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C3547574:insulin degradation [Molecular Function]
   739   C0243125:degradation [Functional Concept]
   739   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "II by a human insulin-degrading enzyme."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   746   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.267: Endocr Res 10:101112[Medline] Garcia JV, Gehm BD, Rosner MR 1989 An evolutionarily conserved enzyme degrades transforming growth factor-alpha as well as insulin. 

Phrase: "Endocr Res 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "101112"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Garcia JV,"

Phrase: "Gehm BD,"

Phrase: "Rosner MR 1989"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347167:Mr. [Conceptual Entity]

Phrase: "An evolutionarily conserved enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "degrades"

Phrase: "transforming growth factor-alpha"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0040688:Transforming Growth Factor alpha [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527195:Transforming Growth Factor-alpha [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C0439095:Alpha [Intellectual Product]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2003941:Alpha [Intellectual Product]
   812   C2350010:Alpha [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "as well as"

Phrase: "insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.268: J Cell Biol 109:13011307[Abstract] Mller D, Schulze C, Baumeister H, Buck F, Richter D 1992 Rat insulin-degrading enzyme: cleavage pattern of the natriuretic peptide hormones ANP, BNP, and CNP revealed by HPLC and mass spectrometry. 

Phrase: "J Cell Biol 109"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "13011307"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mller D,"

Phrase: "Schulze C,"

Phrase: "Baumeister H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Buck F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Richter D 1992 Rat insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   845   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   845   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   795   C0014442:Enzyme [Enzyme,Organic Chemical]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C0014445:enzymes [Functional Concept]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "cleavage pattern of the natriuretic peptide hormones ANP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449774:Pattern [Spatial Concept]

Phrase: "BNP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1095989:BNP [Laboratory Procedure]
  1000   C1417808:BNP [Gene or Genome]
  1000   C2982014:BNP [Gene or Genome]

Phrase: "and"

Phrase: "CNP"

Phrase: "revealed by HPLC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0008562:HPLC [Laboratory Procedure]
   790   C0443289:Revealed [Qualitative Concept]

Phrase: "and"

Phrase: "mass spectrometry."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.269: Biochemistry 31:1113811143[Medline] Fagan JM, Waxman L 1991 Purification of a protease in red blood cells that degrades oxidatively damaged haemoglobin. 

Phrase: "Biochemistry 31"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005477:Biochemistry [Occupation or Discipline]
   861   C0450355:31 [Intellectual Product]

Phrase: ":"

Phrase: "1113811143"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fagan JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Waxman L 1991 Purification of a protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243114:purification [Functional Concept]
   748   C1998793:Purification [Functional Concept]

Phrase: "in red blood cells"
Meta Candidates (Total=24; Excluded=11; Pruned=0; Remaining=13)
  1000   C0014772:Red Blood Cells [Laboratory Procedure]
  1000   C0014792:Red Blood Cells [Cell]
           Red cells
  1000   C0439179:% red blood cells [Quantitative Concept]
  1000   C1277078:Red blood cells [Pharmacologic Substance]
   901   C0005773:Blood Cells [Cell]
   856 E C2328697:Hemal cell [Cell]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0007634:Cells [Cell]
   827   C0229664:Blood [Body Substance]
   827   C0332575:Red [Finding]
   827   C1260956:Red [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "that"

Phrase: "degrades"

Phrase: "oxidatively damaged haemoglobin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.270: Biochem J 277:779786[Medline] Finch PW, Wilson RE, Brown K, Hickson ID, Emmerson PT 1986 Complete nucleotide sequence of the E. coli ptr gene encoding protease III. 

Phrase: "Biochem J 277"

Phrase: ":"

Phrase: "779786"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Finch PW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242397:PW [Geographic Area]

Phrase: "Wilson RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Brown K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hickson ID,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600091:ID [Intellectual Product]

Phrase: "Emmerson PT 1986 Complete nucleotide sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0004793:Nucleotide Sequence [Nucleotide Sequence]
           Sequence
   799   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0162326:Sequence [Nucleotide Sequence]
   799   C0162327:Sequence [Nucleotide Sequence]
   799   C1519249:Sequence [Functional Concept]
   727 E C1548958:Sequential [Idea or Concept]
   727 E C1705294:Sequential [Qualitative Concept]

Phrase: "of the E. coli ptr gene encoding protease III."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   818   C0208233:Protease III [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0439070:III [Intellectual Product]
   795   C1705160:III [Qualitative Concept]
Processing 00000000.tx.271: Nucleic Acids Res 14:76957703[Abstract] Affholter JA, Fried VA, Roth RA 1988 Human insulin-degrading enzyme shares structural and functional homology with E. coli protease III. 

Phrase: "Nucleic Acids Res 14"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0001128:Acids [Chemical]
   812   C0007610:Nucleic [Cell Component]
   812   C2347379:RES [Finding]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ":"

Phrase: "76957703"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Affholter JA,"

Phrase: "Fried VA,"

Phrase: "Roth RA 1988 Human insulin-degrading enzyme"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   845   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   845   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   818   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0014442:Enzyme [Enzyme,Organic Chemical]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   712 E C0014445:enzymes [Functional Concept]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "shares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "structural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structural [Spatial Concept]

Phrase: "and"

Phrase: "functional homology with E. coli protease III."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1334043:Homology [Gene or Genome]
   748   C2697616:Homology [Qualitative Concept]
Processing 00000000.tx.272: Science 242:14151418[Medline] Kuo W-L, Gehm BD, Rosner MR 1991 Cloning and expression of the cDNA for a Drosophila insulin degrading enzyme. 

Phrase: "Science 242"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "14151418"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kuo W-L,"

Phrase: "Gehm BD,"

Phrase: "Rosner MR 1991 Cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "expression of the cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "for a Drosophila insulin degrading enzyme."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.273: Mol Endocrinol 4:15801591[Abstract] Baumeister H, Mller D, Rehbein M, Richter D 1993 The rat insulin-degrading enzyme: molecular cloning and characterization of tissue-specific transcripts. 

Phrase: "Mol Endocrinol 4"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0027960:Mole [Neoplastic Process]
   827   C0324740:Mole [Mammal]
   827   C0439189:Mole [Quantitative Concept]
   827   C1456781:mole [Neoplastic Process]
   827   C1824986:mol [Gene or Genome]
   743 E C0026367:Molar [Body Part, Organ, or Organ Component]
   727 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "15801591"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Baumeister H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Mller D,"

Phrase: "Rehbein M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Richter D 1993"

Phrase: "The rat insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "molecular cloning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "characterization of tissue-specific transcripts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]
Processing 00000000.tx.274: FEBS Lett 317:250254[CrossRef][Medline] Adames N, Blundell K, Ashby MN, Boone C 1995 Role of yeast insulin-degrading enzyme homologs in propheromone processing and bud site selection. 

Phrase: "FEBS Lett 317"

Phrase: ":"

Phrase: "250254"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Adames N,"

Phrase: "Blundell K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ashby MN,"

Phrase: "Boone C 1995 Role of yeast insulin-degrading enzyme homologs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "in propheromone processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "bud site selection."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0036576:selection [Genetic Function]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2700462:Bud [Plant]
   827   C2825164:Site [Spatial Concept]
   827   C2945744:bud [Anatomical Structure]
Processing 00000000.tx.275: Science 270:464467[Abstract] Perlman RK, Gehm BD, Kuo W-L, Rosner MR 1993 Functional analysis of conserved residues in the active site of the insulin degrading enzyme. 

Phrase: "Science 270"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "464467"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Perlman RK,"

Phrase: "Gehm BD,"

Phrase: "Kuo W-L,"

Phrase: "Rosner MR 1993 Functional analysis of conserved residues"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0558024:Functional analysis [Health Care Activity]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "in the active site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205681:Active Site [Functional Concept]
   861   C0205145:Site [Spatial Concept]
   861   C0205177:Active [Functional Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "of the insulin degrading enzyme."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.276: J Biol Chem 268:2153821544[Abstract/Free FullText] Gould SJ, Keller G-A, Hosken N, Wilkinson J, Subramani S 1989 A conserved tripeptide sorts proteins to peroxisomes. 

Phrase: "J Biol Chem 268"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2153821544"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gould SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Keller G-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "A,"

Phrase: "Hosken N,"

Phrase: "Wilkinson J,"

Phrase: "Subramani S 1989"

Phrase: "A conserved tripeptide"

Phrase: "sorts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237886:sort [Mental Process]
  1000   C0700314:sort [Cell Function]
  1000   C1947906:Sort [Activity]

Phrase: "proteins to peroxisomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.277: J Cell Biol 108:16571664[Abstract] Miura S, Kasuya-Arai I, Mori H, Miyazawa S, Osumi T, Hashimoto T, Fujiki Y 1992 Carboxyl-terminal consensus Ser-Lys-Leu-related tripeptide of peroxisomal proteins functions in vitro as a minimal peroxisome-targeting signal. 

Phrase: "J Cell Biol 108"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "16571664"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Miura S,"

Phrase: "Kasuya-Arai I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Mori H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Miyazawa S,"

Phrase: "Osumi T,"

Phrase: "Hashimoto T,"

Phrase: "Fujiki Y 1992 Carboxyl-terminal consensus Ser-Lys-Leu-related tripeptide"

Phrase: "of peroxisomal proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "functions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "in vitro as a minimal peroxisome-targeting signal."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021135:In Vitro [Intellectual Product]
   770   C1533691:in vitro [Qualitative Concept]
           vitro
   770   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.278: J Biol Chem 267:1440514411[Abstract/Free FullText] Subramani S 1993 Protein import into peroxisomes and biogenesis of the organelle. 

Phrase: "J Biol Chem 267"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1440514411"

Phrase: "[Abstract/Free FullText"

Phrase: "] Subramani S 1993 Protein import into peroxisomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1326471:Protein Import [Cell Function]
   748   C0699788:Import [Occupational Activity]

Phrase: "and"

Phrase: "biogenesis of the organelle."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0005495:Biogenesis [Natural Phenomenon or Process]
   770   C0220781:Biogenesis [Biologic Function]
Processing 00000000.tx.279: Annu Rev Cell Biol 9:445478[CrossRef] Van den Bosch H, Schutgens RBH, Wanders RJA, Tager JM 1992 Biochemistry of peroxisomes. 

Phrase: "Annu Rev Cell Biol 9"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0007634:Cell [Cell]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   804   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "445478"

Phrase: "[CrossRef"

Phrase: "] Van den Bosch H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]

Phrase: "Schutgens RBH,"

Phrase: "Wanders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0233569:wander [Finding]

Phrase: "RJA,"

Phrase: "Tager JM 1992 Biochemistry of peroxisomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0005477:Biochemistry [Occupation or Discipline]
Processing 00000000.tx.280: Annu Rev Biochem 61:157197[CrossRef][Medline] Swinkels BW, Gould SJ, Bodnar AG, Rachubinski RA, Subramani S 1991 A novel, cleavable peroxisomal targeting signal at the amino-terminus of the rat 3-ketoacyl-CoA thiolase. 

Phrase: "Annu Rev Biochem 61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "157197"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Swinkels BW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005910:BW [Organism Attribute]
   861   C0006041:BW [Geographic Area]
   861   C2986891:BW [Idea or Concept]

Phrase: "Gould SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Bodnar AG,"

Phrase: "Rachubinski RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Subramani S 1991"

Phrase: "A novel, cleavable peroxisomal targeting signal at the amino-terminus"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   739   C1521840:Targeting [Functional Concept]
   739   C1710082:Signal [Phenomenon or Process]
   739   C3546463:peroxisomal [Cell Component]
   706 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "of the rat 3-ketoacyl-CoA thiolase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0001019:Thiolase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.281: EMBO J 10:32553262[Abstract] Authier F, Rachubinski RA, Posner BI, Bergeron M 1994 Endosomal proteolysis of insulin by an acidic thiol metalloprotease unrelated to insulin degrading enzyme. 

Phrase: "EMBO J 10"

Phrase: ":"

Phrase: "32553262"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Rachubinski RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Posner BI,"

Phrase: "Bergeron M 1994 Endosomal proteolysis of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597304:Proteolysis [Molecular Function]

Phrase: "by an acidic thiol metalloprotease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025543:METALLOPROTEASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "unrelated to insulin degrading enzyme."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0445356:Unrelated [Finding]
   760   C1704623:Unrelated [Qualitative Concept]
Processing 00000000.tx.282: J Biol Chem 269:30103016[Abstract/Free FullText] Kuo W-L, Gehm BD, Rosner MR, Li W, Keller G 1994 Inducible expression and cellular localization of insulin-degrading enzyme in a stably transfected cell line. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "30103016"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kuo W-L,"

Phrase: "Gehm BD,"

Phrase: "Rosner MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Li W,"

Phrase: "Keller G 1994 Inducible expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "cellular localization of insulin-degrading enzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1660642:cellular localisation [Cell Function]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "in a stably transfected cell line."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0007600:Cell Line [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.283: J Biol Chem 269:2259922606[Abstract/Free FullText] Authier F, Bergeron JJM, Ou W-J, Rachubinski RA, Posner BI, Walton PA 1995 Degradation of the cleaved leader peptide of thiolase by a peroxisomal proteinase. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2259922606"

Phrase: "[Abstract/Free FullText"

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Bergeron JJM,"

Phrase: "Ou W-J,"

Phrase: "Rachubinski RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Posner BI,"

Phrase: "Walton PA 1995 Degradation of the cleaved leader peptide of thiolase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C1523817:peptide degradation [Molecular Function]
   738   C0243125:degradation [Functional Concept]
   738   C0699900:Degradation [Organism Function]

Phrase: "by a peroxisomal proteinase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1947941:Proteinase [Enzyme]
Processing 00000000.tx.284: Proc Natl Acad Sci USA 92:38593863[Abstract/Free FullText] Kuo W-L, Montag AG, Rosner MR 1993 Insulin degrading enzyme is differentially expressed and developmentally regulated in various rat tissues. 

Phrase: "Proc Natl Acad Sci USA 92"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "38593863"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kuo W-L,"

Phrase: "Montag AG,"

Phrase: "Rosner MR 1993 Insulin degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C0014445:enzymes [Functional Concept]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "differentially"

Phrase: "expressed"

Phrase: "and"

Phrase: "developmentally"

Phrase: "regulated in various rat tissues."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0040300:Tissues [Tissue]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   726 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.285: Endocrinology 132:604611[Abstract] Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. 

Phrase: "Endocrinology 132"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "604611"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bradford MM 1976"

Phrase: "A rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "sensitive method for the quantitation of microgram quantities of protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   741   C1547724:Quantity method [Idea or Concept]
   739   C0025663:Method [Intellectual Product]
   739   C0449851:Method [Functional Concept]
   739   C0871511:METHOD [Intellectual Product]

Phrase: "utilizing"

Phrase: "the principle of protein-dye binding."
Processing 00000000.tx.286: Anal Biochem 72:248254[CrossRef][Medline] Laemmli UK 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. 

Phrase: "Anal Biochem 72"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003461:Anal [Body Part, Organ, or Organ Component]
   827   C2939124:Anal [Spatial Concept]

Phrase: ":"

Phrase: "248254"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Laemmli UK 1970 Cleavage of structural proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0597304:Protein Cleavage [Molecular Function]
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "during the assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706853:Assembly [Activity]
  1000   C1879748:Assembly [Manufactured Object]

Phrase: "of the head"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0018670:Head [Body Location or Region]
  1000   C1281590:Head [Body Part, Organ, or Organ Component]
  1000   C1706305:Head [Manufactured Object]
   944 E C0205096:Cephalic [Spatial Concept]

Phrase: "of bacteriophage T4."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162570:Bacteriophage T4 [Virus]
Processing 00000000.tx.287: Nature 227:680685[Medline] Perlman RK, Rosner MR 1994 Identification of zinc ligands of the insulin-degrading enzyme. 

Phrase: "Nature 227"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "680685"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Perlman RK,"

Phrase: "Rosner MR 1994 Identification of zinc ligands of the insulin-degrading enzyme."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0020792:Identification [Mental Process]
   736   C0205396:Identification [Qualitative Concept]
Processing 00000000.tx.288: J Biol Chem 269:3314033145[Abstract/Free FullText] Deng WP, Nickoloff JA 1992 Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "3314033145"

Phrase: "[Abstract/Free FullText"

Phrase: "] Deng WP,"

Phrase: "Nickoloff JA 1992 Site-directed mutagenesis of virtually"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   767   C2945843:Site of [Qualitative Concept]
   744   C0079866:Mutagenesis [Molecular Function]
   744   C0205145:Site [Spatial Concept]
   744   C1515974:Site [Body Location or Region]
   744   C2825164:Site [Spatial Concept]
   744   C3146302:Mutagenesis [Laboratory Procedure]
   711   C0439851:Direct [Qualitative Concept]
   711   C1947931:Direct [Qualitative Concept]

Phrase: "any plasmid by eliminating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "a unique site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]
Processing 00000000.tx.289: Anal Biochem 200:8188[Medline] Sambrook J, Fritsch EF, Maniatis T 1989 Molecular Cloning: A Laboratory Manual. 

Phrase: "Anal Biochem 200"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003461:Anal [Body Part, Organ, or Organ Component]
   827   C2939124:Anal [Spatial Concept]

Phrase: ":"

Phrase: "8188"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sambrook J,"

Phrase: "Fritsch EF,"

Phrase: "Maniatis T 1989 Molecular Cloning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   804   C0009015:Cloning [Research Activity]

Phrase: ":"

Phrase: "A Laboratory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022877:Laboratory [Manufactured Object,Organization]
  1000   C3244292:laboratory [Functional Concept]

Phrase: "Manual."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024763:Manual [Intellectual Product,Manufactured Object]
  1000   C0175674:Manual [Functional Concept]
Processing 00000000.tx.290: Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York Keller G-A, Gould S, Deluca M, Subramani S 1987 Firefly luciferase is targeted to peroxisomes in mammalian cells. 

Phrase: "Cold Spring Harbor Laboratory Press,"

Phrase: "Cold Spring Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475311:Harbor [Manufactured Object]

Phrase: "New York Keller G-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "A,"

Phrase: "Gould S,"

Phrase: "Deluca M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Subramani S 1987 Firefly luciferase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0311727:Firefly luciferase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   804   C0162328:Firefly [Eukaryote]

Phrase: "is"

Phrase: "targeted to peroxisomes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0752063:Peroxisomes [Cell Component]
   790   C1521840:Targeted [Functional Concept]
   756 E C2984308:Peroxisome [Functional Concept]
   756 E C2986546:TARGET [Diagnostic Procedure]
   706 E C3546463:peroxisomal [Cell Component]

Phrase: "in mammalian cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.291: Proc Natl Acad Sci USA 84:32643268[Abstract] Kamijo K, Taketani S, Yokota S, Osumi T, Hashimoto T 1990 The 70-kDa peroxisomal membrane protein is a member of the Mdr (P-glycoprotein)-related ATP-binding protein superfamily. 

Phrase: "Proc Natl Acad Sci USA 84"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "32643268"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kamijo K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Taketani S,"

Phrase: "Yokota S,"

Phrase: "Osumi T,"

Phrase: "Hashimoto T 1990"

Phrase: "The 70-kDa peroxisomal membrane protein"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   840   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1179904:Peroxisomal membrane [Cell Component]
   804   C0025255:Membrane [Tissue]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0596901:Membrane [Cell Component]
   804   C1706182:Membrane [Manufactured Object]
   804   C3546463:peroxisomal [Cell Component]
   733 E C0205287:Membranous [Qualitative Concept]
   733 E C0752063:Peroxisomes [Cell Component]
   733 E C2984308:Peroxisome [Functional Concept]

Phrase: "is"

Phrase: "a member of the Mdr (P-glycoprotein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0680022:member [Population Group]
   748   C2698041:Member [Professional or Occupational Group]

Phrase: ")-"

Phrase: "related ATP-binding protein superfamily."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1883220:Superfamily [Conceptual Entity]
Processing 00000000.tx.292: J Biol Chem 265:45344540[Abstract/Free FullText] Gould SJ, Keller G-A, Subramani S 1988 Identification of peroxisomal targeting signals located at the carboxy terminus of four peroxisomal proteins. 

Phrase: "J Biol Chem 265"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "45344540"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gould SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Keller G-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "A,"

Phrase: "Subramani S 1988 Identification of peroxisomal targeting signals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0020792:Identification [Mental Process]
   744   C0205396:Identification [Qualitative Concept]

Phrase: "located at the carboxy terminus of four peroxisomal proteins."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205450:Four [Quantitative Concept]
   742   C0596260:Carboxy [Organic Chemical]
   742   C3546463:peroxisomal [Cell Component]
Processing 00000000.tx.293: J Cell Biol 107:897905[Abstract] Van der Klei IJ, Sulter GJ, Harder W, Veenhuis M 1991 Assembly of alcohol oxidase in the cytosol of a peroxisome-deficient mutant of Hansenula polymorpha  properties of the protein and architecture of the crystals. 

Phrase: "J Cell Biol 107"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "897905"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Van der Klei IJ,"

Phrase: "Sulter GJ,"

Phrase: "Harder W,"

Phrase: "Veenhuis M 1991 Assembly of alcohol oxidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1706853:Assembly [Activity]
   748   C1879748:Assembly [Manufactured Object]

Phrase: "in the cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "of a peroxisome-deficient mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "of Hansenula polymorpha  properties"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0871161:properties [Qualitative Concept]
   827   C1292721:properties [Functional Concept]
   793 E C1882134:Property [Conceptual Entity]
   793 E C2347695:Property [Entity]
   734   C0319605:Hansenula polymorpha [Fungus]

Phrase: "of the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "architecture of the crystals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0003737:Architecture [Occupation or Discipline]
Processing 00000000.tx.294: Yeast 7:1524 McCollum D, Monosov E, Subramani S 1993 The pas8 mutant of Pichia pastoris exhibits the peroxisomal protein import deficiencies of Zellweger syndrome cells  the PAS8 protein binds to the COOH-terminal tripeptide peroxisomal targeting signal, and is a member of the TPR protein family. 

Phrase: "Yeast 7"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036025:yeast [Fungus]
   861   C0043392:Yeast [Food]
   861   C0043393:Yeast [Fungus]
   861   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: ":"

Phrase: "1524 McCollum D,"

Phrase: "Monosov E,"

Phrase: "Subramani S 1993"

Phrase: "The pas8 mutant of Pichia pastoris"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "the peroxisomal protein import deficiencies of Zellweger syndrome cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0033626:Protein Deficiencies [Disease or Syndrome]
   709   C3279400:Peroxisome deficiency [Finding]
   708   C0011155:Deficiency [Functional Concept]
   708   C0162429:Deficiency [Disease or Syndrome]
   708   C1623416:deficiency [Qualitative Concept]

Phrase: "the PAS8 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binds to the COOH-terminal tripeptide peroxisomal targeting signal,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   742   C0205088:Terminal [Temporal Concept]
   742   C1145667:Bind [Activity]
   742   C1167622:bind [Molecular Function]
   742   C1521840:Targeting [Functional Concept]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   742   C1710082:Signal [Phenomenon or Process]
   742   C3546463:peroxisomal [Cell Component]
   708 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "and"

Phrase: "is"

Phrase: "a member of the TPR protein family."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0086282:Family member [Family Group]
   774   C1611821:Family Member [Intellectual Product]
   748   C0680022:member [Population Group]
   748   C2698041:Member [Professional or Occupational Group]
Processing 00000000.tx.295: J Cell Biol 121:761774[Abstract] Walton PA, Wendland M, Subramani S, Rachubinski RA 1994 Involvement of 70 kD heat-shock proteins in peroxisomal import. 

Phrase: "J Cell Biol 121"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "761774"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Walton PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Wendland M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Subramani S,"

Phrase: "Rachubinski RA 1994 Involvement of 70 kD heat-shock proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1314939:Involvement [Functional Concept]

Phrase: "in peroxisomal import."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0699788:Import [Occupational Activity]
Processing 00000000.tx.296: J Cell Biol 125:10371046[Abstract] Authier F, Cameron PH, Taupin V 1996 Association of insulin-degrading enzyme with a 70 kDa cytosolic protein in hepatoma cells. 

Phrase: "J Cell Biol 125"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "10371046"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Cameron PH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "Taupin V 1996 Association of insulin-degrading enzyme"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "with a 70 kDa cytosolic protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in hepatoma cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C0677626:hepatoma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0023903:Hepatoma [Neoplastic Process]
   861   C2239176:Hepatoma [Neoplastic Process]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.297: Biochem J 319:149158[Medline] Bulitta C, Ganea C, Fahimi HD, Vlkl A 1996 Cytoplasmic and peroxisomal catalases of the guinea pig liver: evidence for two distinct proteins. 

Phrase: "Biochem J 319"

Phrase: ":"

Phrase: "149158"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bulitta C,"

Phrase: "Ganea C,"

Phrase: "Fahimi HD,"

Phrase: "Vlkl"

Phrase: "A 1996 Cytoplasmic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010834:Cytoplasmic [Cell Component]
   861   C0521449:Cytoplasmic [Body Location or Region]

Phrase: "and"

Phrase: "peroxisomal catalases of the guinea pig liver"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0007367:catalases [Amino Acid, Peptide, or Protein,Enzyme]
   714 E C1413138:CATALASE [Gene or Genome]

Phrase: ":"

Phrase: "evidence for two distinct proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.298: Biochim Biophys Acta 1293:5562[Medline] Lin YJ, Harada S, Loten EG, Smith RM, Jarett L 1992 Direct stimulation of immediate-early genes by intranuclear insulin in trypsin-treated H35 hepatoma cells. 

Phrase: "Biochim Biophys Acta 1293"

Phrase: ":"

Phrase: "5562"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lin YJ,"

Phrase: "Harada S,"

Phrase: "Loten EG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013715:EG [Geographic Area]
   861   C1705651:EG [Idea or Concept]

Phrase: "Smith RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Jarett L 1992 Direct stimulation of immediate-early genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   742   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "by intranuclear insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in trypsin-treated H35 hepatoma cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0677626:hepatoma cell [Cell]
   804   C0007634:Cells [Cell]
   804   C0023903:Hepatoma [Neoplastic Process]
   804   C2239176:Hepatoma [Neoplastic Process]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.299: Proc Natl Acad Sci USA 89:96919694[Abstract] Harada S, Smith RM, Smith J-A, Jarret L 1993 Inhibition of insulin-degrading enzyme increases translocation of insulin to the nucleus in H35 rat hepatoma cells: evidence of a cytosolic pathway. 

Phrase: "Proc Natl Acad Sci USA 89"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "96919694"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Harada S,"

Phrase: "Smith RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Smith J-"

Phrase: "A,"

Phrase: "Jarret L 1993 Inhibition of insulin-degrading enzyme"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0877008:enzyme inhibition [Disease or Syndrome]
   767   C1524081:Enzyme Inhibition [Physiologic Function]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "translocation of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0040715:Translocation [Cell or Molecular Dysfunction]
   790   C2987521:Translocation [Activity]

Phrase: "to the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "in H35 rat hepatoma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0677626:hepatoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0023903:Hepatoma [Neoplastic Process]
   812   C2239176:Hepatoma [Neoplastic Process]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "evidence of a cytosolic pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332120:Evidence of [Functional Concept]
           Evidence
Processing 00000000.tx.300: Endocrinology 132:22932298[Abstract] Shah N, Zhang S, Harada S, Smith SM, Jarett L 1995 Electron microscopic visualization of insulin translocation into the cytoplasm and nuclei of intact H35 hepatoma cells using covalently linked nanogold-insulin. 

Phrase: "Endocrinology 132"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "22932298"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Shah N,"

Phrase: "Zhang S,"

Phrase: "Harada S,"

Phrase: "Smith SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Jarett L 1995 Electron microscopic visualization of insulin translocation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0175631:Visualization [Mental Process]
   742   C2827662:Visualization [Occupation or Discipline]

Phrase: "into the cytoplasm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "and"

Phrase: "nuclei of intact H35 hepatoma cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   798   C0007610:Nucleus of cell [Cell Component]
           Cell Nuclei
           Nucleus

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "covalently linked nanogold-insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.301: Endocrinology 136:28252835[Abstract] Moss AL, Ward WF 1991 Multiple pathways for ligand internalization in rat hepatocytes II: effect of hyperosmolarity and contribution of fluid-phase endocytosis. 

Phrase: "Endocrinology 136"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "28252835"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Moss AL,"

Phrase: "Ward WF 1991 Multiple pathways for ligand internalization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1704259:Pathways [Molecular Function]
   744   C1705987:Pathways [Conceptual Entity]

Phrase: "in rat hepatocytes II"

Phrase: ":"

Phrase: "effect of hyperosmolarity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "contribution of fluid-phase endocytosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]
Processing 00000000.tx.302: J Cell Physiol 149:319323[Medline] Backer JM, Shoelson SE, Haring E, White MF 1991 Insulin receptors internalize by a rapid, saturable pathway requiring receptor autophosphorylation and an intact juxtamembrane region. 

Phrase: "J Cell Physiol 149"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "319323"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Backer JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Shoelson SE,"

Phrase: "Haring"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0242372:haring [Mammal]
   966 E C1425660:HARE [Gene or Genome]

Phrase: "E,"

Phrase: "White MF 1991 Insulin receptors"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   840   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   806 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "internalize by a rapid, saturable pathway requiring receptor autophosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0439831:Rapid [Qualitative Concept]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0813988:autophosphorylation [Molecular Function]
   742   C1704259:Pathway [Molecular Function]
   742   C1705987:Pathway [Conceptual Entity]

Phrase: "and"

Phrase: "an intact juxtamembrane region."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.303: J Cell Biol 115:15351545[Abstract] Braun H-P, Schmitz U 1995 Are the core proteins of the mitochondrial bc1 complex evolutionary relics of a processing protease. 

Phrase: "J Cell Biol 115"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "15351545"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Braun H-P,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Schmitz U 1995"

Phrase: "Are"

Phrase: "the core proteins of the mitochondrial bc1 complex evolutionary relics"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C2336600:Mitochondrial protein complex [Cell Component]
   757   C0949610:Mitochondrial Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741   C1523872:protein complex [Cell Component]
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0444669:Core [Spatial Concept]
   739   C1167518:core [Cell Component]
   739   C1706352:Core [Medical Device]
   739   C1882467:Core [Manufactured Object]
   739   C3274653:Core [Body Substance]

Phrase: "of a processing protease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]
Processing 00000000.tx.304: Trends Biochem Sci 20:171175[CrossRef][Medline] Brunner M, Neupert W 1995 Purification and characterization of mitochondrial processing peptidase of Neurospora crassa. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem Sci 20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "171175"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Brunner M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Neupert W 1995 Purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0243114:purification [Functional Concept]
   812   C1998793:Purification [Functional Concept]

Phrase: "and"

Phrase: "characterization of mitochondrial processing peptidase of Neurospora crassa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880022:Characterization [Activity]
Processing 00000000.tx.305: Methods Enzymol 248:717728[Medline]

Phrase: "Methods Enzymol 248"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "717728"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

